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Abstract
Background: We have used a genetical genomic approach, in conjunction with phenotypic
analysis of alcohol consumption, to identify candidate genes that predispose to varying levels of
alcohol intake by HXB/BXH recombinant inbred rat strains. In addition, in two populations of
humans, we assessed genetic polymorphisms associated with alcohol consumption using a custom
genotyping array for 1,350 single nucleotide polymorphisms (SNPs). Our goal was to ascertain
whether our approach, which relies on statistical and informatics techniques, and non-human
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studies with human populations.
Results: In the HXB/BXH recombinant inbred (RI) rats, correlation analysis of brain gene
expression levels with alcohol consumption in a two-bottle choice paradigm, and filtering based on
behavioral and gene expression quantitative trait locus (QTL) analyses, generated a list of candidate
genes. A literature-based, functional analysis of the interactions of the products of these candidate
genes defined pathways linked to presynaptic GABA release, activation of dopamine neurons, and
postsynaptic GABA receptor trafficking, in brain regions including the hypothalamus, ventral
tegmentum and amygdala. The analysis also implicated energy metabolism and caloric intake
control as potential influences on alcohol consumption by the recombinant inbred rats. In the
human populations, polymorphisms in genes associated with GABA synthesis and GABA receptors,
as well as genes related to dopaminergic transmission, were associated with alcohol consumption.
Conclusion: Our results emphasize the importance of the signaling pathways identified using the
non-human animal models, rather than single gene products, in identifying factors responsible for
complex traits such as alcohol consumption. The results suggest cross-species similarities in
pathways that influence predisposition to consume alcohol by rats and humans. The importance of
a well-defined phenotype is also illustrated. Our results also suggest that different genetic factors
predispose alcohol dependence versus the phenotype of alcohol consumption.
Background
The term "genetical genomics" is entering the common
parlance of researchers, denoting the combined use of
genetic marker information and transcriptome analysis.
Complex trait phenotyping can be fruitfully combined
with genetical genomic analysis to ascertain the candidate
genes and gene product interaction pathways which sig-
nificantly influence the variation in expression of a phe-
notype of interest. We and others have utilized the
genetical genomics and phenomic approaches to identify
genes and pathways important in genetically influenced
complex traits such as obesity, respiratory function and
"addictive" behavior [1-3]. In the area of addictive behav-
ior, our laboratory has focused on certain endopheno-
types, including the genetic contributors to acute
functional tolerance to ethanol [4,5] and alcohol prefer-
ence in mice [2]. These studies produced results that
implicated the protein products of genes important in
learning and memory as contributors to acute functional
tolerance to ethanol, and proteins important in orosen-
sory systems and information processing as being impor-
tant in alcohol preference in mice.
The genus/species Rattus norvegicus has been used exten-
sively in studies of addictive behavior, not only with
regard to ethanol, but also to cocaine, opiates, cannabi-
noids, nicotine, etc. [6,7]. Although several research
groups have suggested that similar or identical biochemi-
cal systems in particular brain areas mediate self-adminis-
tration of addictive drugs [6,8-10], such proposals have
not been tested by applying the unbiased approach of
genetical genomics, combined with phenotyping, to stud-
ies with rats. In the present study, we have used the HXB/
BXH recombinant inbred rat strains [11], which represent
a unique resource for alcohol research. These rats have
previously been used for quantitative trait locus (QTL)
analysis of various cardiovascular phenotypes and meta-
bolic and behavioral traits [11]. We have generated brain
transcriptome data for 28 recombinant inbred strains of
HXB/BXH rats [11], and have combined these data with
genetic marker data for these animals [12]. We have also
tested the rats in a standard procedure for measuring alco-
hol preference [13] and these data have allowed us to gen-
erate insight into a complex of genes and their protein
products which have significant association with the trait
of alcohol preference/consumption in rats.
We have also taken the opportunity to directly compare
the candidate genes and pathways for alcohol consump-
tion that we identified using the rodent model, to candi-
date genes in human populations. We used the
"Addictions Array" [14] to assess the relationships among
a panel of genetic markers (SNPs) for "alcoholism and
addiction" candidate genes, and the phenotype of alcohol
consumption, in two populations of humans that had
been characterized in the WHO/ISBRA Study on State and
Trait Markers of Alcohol Dependence [15]. The results of
this analysis demonstrate a convergence of the human
and animal results and provide a differentiation between
the genetic polymorphisms associated with predisposi-
tion to alcohol drinking and the susceptibility to alcohol
dependence.Page 2 of 23
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Animal Studies
Animals
Male rats from well-characterized HXB/BXH recombinant
inbred (RI) rat strains [11] were used for these studies. The
rats were rederived into and maintained in a colony at the
University of California, San Diego. These rats were devel-
oped from an intercross between two inbred strains, the
Wistar origin spontaneously hypertensive rat (SHR/Ola)
and Brown Norway congenic (BN-Lx/Cub) [11]. The RI
strains replicate the F2 generation of the intercross and
have been brother-sister mated for more than 90 genera-
tions. Development of the RI strain set utilized gender
reciprocal crossing, providing two strain sets that differ in
the source of mitochondrial DNA and the Y chromosome.
The HXB rats carry mitochondrial DNA from the SHR rats
and the Y chromosome from the BN-Lx rats, while the
BXH strains are the reverse.
Alcohol Consumption
Data on alcohol consumption were gathered on 23 HXB/
BXH strains and the two progenitor strains. The number
of rats per strain ranged from 9 to 12, with 242 total rats
being utilized to measure alcohol consumption. In the
first week (week 0) of treatment, rats were given 10% eth-
anol as their only choice of fluid. For the next seven weeks
(week 1 - week 7), the rats were given a choice of two bot-
tles, one with water and one with a 10% (v/v) ethanol
solution [13]. Volumes of water and alcohol solution con-
sumed were measured by weight on Monday, Wednesday
and Friday of each week. The placement of the two bottles
was varied after each measurement to avoid a place pref-
erence effect. For the current study we used alcohol con-
sumption data from the second week of the two-bottle
choice paradigm. These data were chosen to reflect a sta-
ble level of alcohol consumption/"preference" and to
facilitate comparisons with alcohol consumption/prefer-
ence in rats selectively bred for this trait [7], which use a
similar paradigm for selection. The stability of this meas-
ure was confirmed by comparison of the mean levels of
alcohol consumption for each strain during week 2 and
week 7 of the two-bottle choice procedure. A correlation
analysis resulted in an r2 = 0.62 (P < 0.001).
Behavioral QTL Analysis
Behavioral QTLs (bQTLs) were calculated for the alcohol
consumption phenotype using strain means for average
daily alcohol consumption in grams per kilogram during
week 2 of the two-bottle choice period. Individual values
were not included if they were more than two standard
deviations from the strain mean. The recently developed
STAR Consortium SNP set of genetic markers was used in
this QTL analysis [12]. There were 21 recombinant inbred
strains plus the two progenitor strains that had both alco-
hol consumption data and SNP data. Using these 23
strains, 962 unique strain distribution patterns were iden-
tified in the STAR Consortium SNP set. Strain means for
alcohol consumption were used in a marker regression
QTL analysis. QTLs with empirical P-values less than 0.05
[based on permutation, [16]] were considered significant,
and markers with logarithm of odds (LOD) scores above
2.0 were considered "suggestive" and were included as
potential bQTL for alcohol consumption. The 20 Mb
region around the significant and suggestive markers was
used as the bQTL interval. bQTL analyses were conducted
using the R/qtl package in R [17].
Microarray Analysis
Naive (non alcohol-exposed) male HXB/BXH RI rats were
used for microarray analysis. Rats were group-housed and
individual rats were quickly anesthetized with iso-
fluorane/air and decapitated according to a protocol
approved by the UCSD IACUC. Brains were rapidly
removed, sectioned sagittally into two hemispheres, and
frozen on dry ice or in liquid nitrogen. The right half-hem-
ispheres were promptly shipped on dry ice to the Univer-
sity of Colorado, where they were kept at -80°C until used
for RNA extraction. CodeLink Rat Whole Genome Bioar-
rays were obtained from G.E. Healthcare/Amersham Bio-
sciences (Piscataway, NJ).
Total RNA Extraction
RNA from the right halves of brains of five to seven rats
per strain (26 RI strains and the progenitor strains) was
used for these experiments (our prior studies and those of
others [18] showed no statistically significant differences
in gene expression between left and right halves of rodent
brain). Brains were homogenized in lysis buffer using a
Polytron (Brinkmann Instruments, Westbury, NY, USA),
and total RNA was isolated using the RNeasy Midi Kit
(Qiagen) (Valencia, CA, USA) following the protocol sup-
plied by the manufacturer. An additional clean-up of total
RNA was carried out using the RNeasy Mini Kit (Qiagen).
Quality of the samples was assessed on an Agilent Bioan-
alyzer (Agilent Technologies, Santa Clara, CA, USA).
Expression Analysis Using CodeLink Rat Bioarrays
Each CodeLink Rat Whole Genome Bioarray used in these
experiments has ~34,000 probes for rat transcripts and
expressed sequence tags (ESTs), plus a number of positive
and negative control probes. Using the protocol supplied
by the manufacturer, double-stranded cDNA was synthe-
sized from the total RNA (4 μg of total RNA from an indi-
vidual rat brain was used for each array) and was used to
obtain biotin-labeled cRNA by an in vitro transcription
reaction. Biotin-labeled cRNA was recovered using the
RNeasy kit (Qiagen) and concentration and purity were
assessed spectrophotometrically. Biotin-labeled cRNA
from each rat was then fragmented and hybridized with
an individual CodeLink Bioarray. The Bioarrays were sub-Page 3 of 23
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washed before scanning. Arrays were scanned using a
GenePix 4000B Scanner [Axon Instruments (Molecular
Devices Corp), Union City, CA, USA] and the images were
quantitated with CodeLink Expression Analysis (v 4.1)
software (Amersham Biosciences).
Quality Control and Normalization
Raw intensity values were obtained from the CodeLink
processing software. Entire arrays were examined for qual-
ity control purposes both before and after normalization.
Before normalization, arrays were examined by boxplots
and coefficient of variation (CV) plots for consistency,
along with background levels and proportion of probes
within each category for the CodeLink quality flags. After
normalization, samples were examined using hierarchical
clustering and pair-wise scatter plots to identify samples
that severely deviated from other samples within the same
strain (such samples were eliminated from further analy-
sis).
In preparation for normalization, probes were removed
from the datasets if they were one of the negative or posi-
tive controls placed on the array by the manufacturer.
Next, individual values were eliminated based on the
quality flags assigned by the CodeLink Expression Analy-
sis Software. Values were eliminated if they were flagged
as M (spot was identified to be defective through image
inspection at manufacturing), C (spot has a high level of
background contamination), I (spot has an irregular
shape), or S (spot has a high number of saturated pixels).
Values were retained if they were flagged G (spot is good)
or L (spot is below local background noise). In addition,
to be able to take the log base 2 transformation of the
background adjusted intensity values, all background
adjusted intensity values below zero were replaced with
the value 0.00001. The data were then normalized using a
cyclic LOESS (locally weighted scatterplot smoothing)
procedure executed in R which accounted for the missing
intensity values. Normalization and quality control were
executed in R using the affy, codelink, and limma pack-
ages [19].
Identification of Candidate Genes for Alcohol Consumption
After normalization of the expression data, several filters
were applied in order to identify candidate genes for alco-
hol preference in the HXB/BXH RI strains.
Annotation Filter
Probes were eliminated from further analysis if they did
not represent a valid gene. Each probe is represented by a
30-mer base sequence. These 30-mers were compared to
the most recent (November 2004) assembly of the rat
genome using the BLAST-like alignment tool (BLAT)
available from the UCSC website [20]. A probe was
retained if at least 28 of the bases matched a region in the
genome with less than a two base gap within the
sequence. This region also had to fall within an estab-
lished exon for a RefSeq rat gene, or within an exon
sequence for a RefSeq mouse or human gene whose entire
sequence matched a region in the rat genome.
Expression QTL analysis
Expression QTL (eQTL) were established using the HXB/
BXH RI brain gene expression data. For this analysis, 26
strains (2 progenitor strains and 24 RI strains) were repre-
sented among 124 samples (data from two strains for
which genotyping was not available were not included).
The quality control measures and normalization proce-
dures described above were utilized. The STAR marker set
described in the behavioral QTL methods section was also
utilized in this analysis. Because more strains were
included in this analysis than in the bQTL analysis, 1,184
unique strain distribution patterns were represented in
this marker set.
To calculate eQTLs, mean expression levels within strains
were used as phenotypic values in a QTL analysis imple-
mented in QTLReaper, which is written in C and compiled
as a Python module. A weighted marker regression analy-
sis was used within this program to calculate likelihood
ratio statistic (LRS) scores for each marker. LRS scores
were transformed to LOD scores for convenience by divid-
ing by 4.61. The regression is weighted to account for the
different number of arrays within strains used to calculate
strain means. The weight is based on the repeatability of
the transcript intensity and number of arrays used to cal-
culate the strain mean [21]. The empirical P-value with
respect to the maximum LOD score was calculated for
each transcript by permutation [16]. The number of per-
mutations per transcript was increased until the maxi-
mum LOD score from the true data was no longer in the
top ten of LOD scores from the permutation, or until
1,000,000 permutations were calculated. For eQTLs with
empirical P-values less than 0.10, 95% confidence limits
for location were calculated using 1,000 bootstrap sam-
ples [22]. Probes were retained if they had a significant (P
< 0.05) or suggestive (P < 0.10) eQTL.
eQTL/bQTL overlap filter
Probes whose eQTL 95% confidence interval for genomic
location overlapped the chromosomal location of any of
the four behavioral QTLs were retained for further consid-
eration.
Heritability Filter
A broad-sense heritability was calculated for each probe in
the expression data used in the correlation analysis.
Probes were retained if they had a broad sense heritability
≥ 50%.Page 4 of 23
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Detection limits are calculated by the CodeLink software
as the median intensity of the local background plus 1.5
local background standard deviations. Probes were elimi-
nated if values were below detection limits for ≥ 50% of
the samples.
Correlation Filter
The correlation of alcohol consumption and gene expres-
sion was modeled using a joint mixed model for both the
expression and alcohol consumption data, Yijk = μk + sik +εijk for i = 1,...,25 strains, j = 1,...nik rats, and k = 1,2 where
k = 1 indicates a gene expression measure and k = 2 indi-
cates an alcohol consumption measure. The εijk are inde-
pendent and identically distributed from a normal
distribution with a 0 mean and a measure-specific vari-
ance (σk2). The sik are random strain-measurement effects.
The pair, [si1, si2], are independent and identically distrib-
uted as a bivariate normal with an unstructured covari-
ance where a separate between-strain variance is
calculated for expression and alcohol consumption plus a
covariance between expression and alcohol consumption.
This model was executed in SAS version 9.1 using a maxi-
mum likelihood model in the linear mixed model func-
tion called PROC MIXED. A likelihood ratio statistic was
used to determine if the covariance between gene expres-
sion and alcohol consumption is significantly different
from zero. Probes which demonstrated an overlap of their
eQTL location and the genomic location of one of the four
bQTLs and which passed the other filters listed above,
were used in our correlation analysis. Probes were
retained if they had a significant covariance with alcohol
consumption (P < 0.05).
Proportion of Variance Explained and Model Building
Once a list of candidate genes was established, the propor-
tion of genetic variance in alcohol consumption among
strains that was explained by gene expression was exam-
ined. A multivariate genetic model for alcohol consump-
tion was constructed using a linear regression with strain
means for both gene expression and alcohol consump-
tion. Genes were selected for inclusion using a forward
stepwise selection process with a significance criterion of
0.01 for entrance into the model. A forward selection
method was chosen over a backward selection method in
this instance because of the large number of potential cov-
ariates (candidate genes). The proportion of genetic vari-
ance explained was determined for each candidate gene
individually and for the combination of transcripts in the
final multivariate genetic model which described the
strain variation in alcohol consumption.
Functional Analysis of Candidate Gene Products
In order to determine the functions of the candidate gene
products, and assemble them into pathways, a literature
search was performed using PubMed. The gene symbols
(NCBI) and gene product names were used as key words.
Replication Studies
In order to replicate differences in gene expression associ-
ated with alcohol consumption, gene expression profiles
were analyzed using Affymetrix GeneChip Rat Gene 1.0 ST
arrays (Affymetrix, Santa Clara, CA, USA), which utilize
probesets that span the coding region of each gene. RNA
from brains of five male rats from HXB RI strain 23 (low
alcohol consumption) and five male rats from HXB RI
strain 26 (high alcohol consumption) was used for these
studies. These particular strains were chosen because the
expression levels of all of the candidate genes (assayed on
the CodeLink arrays (Amersham Biosciences)) showed an
appropriate direction of differential expression, compared
to the correlation analysis, although not all of the differ-
ences in the candidate gene expression were statistically
significant between these particular strains. RNA (0.3 μg
per rat) was processed and hybridized to the Affymetrix
arrays (cDNA from one rat to each individual array)
according to the manufacturer's protocol. Arrays were
labeled and scanned as previously described [2]. For data
analysis, raw data and the normalized probeset data were
assessed for quality using the 'aroma.affymetrix' package
in R [23] and Expression Console from Affymetrix [24].
All ten arrays passed quality control. Raw intensity values
for individual probes were corrected for background using
the RMA correction, probe values were quantile normal-
ized, and probes were summarized into probesets [25] in
aroma.affymetrix. The probe intensities were compared
between the two strains using a two-sample t-test assum-
ing unequal variance on both the probeset and the probe
level. Probe level data were only examined for those
probes that fell within the same exon, upstream, or down-
stream region as the original CodeLink probe.
Human Association Study
Population
Subjects for the human genetics association study were
recruited as part of the WHO/ISBRA Study on State and
Trait Markers of Alcohol Use and Dependence [15]. More
specifically, phenotypic data from Caucasian subjects
from Montreal, Canada and Sydney, Australia were ana-
lyzed since these subjects were also genotyped using the
Addiction Array [14]. The phenotypic data were collected
using a structured interview instrument that was devel-
oped for the WHO/ISBRA Study. This instrument was
developed in concert with the development of the Alcohol
Use Disorders and Associated Disabilities Interview
Schedule (AUDADIS), and included eight major sections
[see [15]]. Of particular relevance for the current study,
the interview included a section that gathered informa-
tion on beverage-specific frequency and quantity of alco-
hol drinking during the past 30 days, and the symptomsPage 5 of 23
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tion gathered information that allowed for International
Classification of Diseases -10 (ICD-10) and Diagnostic
and Statistical Manual -IV (DSM-IV) diagnosis of alcohol
abuse, dependence and withdrawal syndromes. In addi-
tion, family history of alcohol problems or alcohol
dependence, major depression, drug use and abuse and
other psychiatric problems were assessed (see Additional
file 1, Table S2). Additional information on the demo-
graphic characteristics of the human subjects is contained
in Additional file 1, Table S3. For more details on the orig-
inal study and data collection, see Glanz et al. [15].
SNPs
Genotype data were obtained from a custom array using
the Illumina Goldengate SNP technology assay platform.
This array includes a panel of markers designed to extract
full haplotype information for 130 candidate genes asso-
ciated with alcoholism, other drug addictions, and mood
and anxiety disorders. The design and performance of this
array are described in detail by Hodgkinson et al. [14].
Briefly, the array contains 1,350 tagSNPs representing the
130 addiction-related genes, and an additional 186 mark-
ers identified as highly informative for ancestry (AIMs).
Outcome Measure
The main phenotypic outcome measure of this analysis
was alcohol consumption reported in grams per kilogram
of body weight per day. The total amount of alcohol con-
sumed in the last 30 days was calculated based on infor-
mation that was collected in the WHO/ISBRA
questionnaire on beverage-specific frequency and quan-
tity of drinking and this total was divided by 30 to obtain
the daily average.
Quality Control
Prior to the univariate analyses, the SNP dataset was sub-
jected to strict quality control standards. Individual SNPs
were eliminated if they were not in Hardy-Weinberg equi-
librium (FDR<0.01) or if they had minor allele frequency
less than 5%. Subjects were eliminated if their genotype
was not determined for at least 80% of the SNPs according
to standards set forth in Hodgkinson et al. [14]. The ances-
try informative markers were not considered in any of the
association analyses with the exception of the tests for
stratification.
Population Stratification
Since the subjects came from two distinct geographical
locations, it is reasonable to consider that there may be
some genetic differences between these populations. Pop-
ulation stratification with respect to the outcome, alcohol
consumption, was tested against the AIMs using the con-
cept outlined in Pritchard and Rosenberg [26]. A Fisher's
combined probability test was used to calculate signifi-
cance, due to the continuous nature of the outcome. Dif-
ferences in allele frequencies between the two
populations for the AIMs were also tested using Pritchard
and Rosenberg's [26] method of combining chi-square
statistics.
Univariate Analyses
The association between alcohol consumption and each
individual SNP was tested in an ANOVA using a genotype
model. P-values were adjusted using a false discovery rate
(FDR). SNPs with an FDR < 0.05 were considered to show
a significant association.
Haplotypes
Haplotype blocks were determined in Haploview [27] for
genes with significant SNPs, using the Gabriel et al. [28]
method for identifying block boundaries. Haplotype
block structure was examined in the WHO/ISBRA popula-
tion that had the significant SNP association, and in the
CEPH (Utah Residents with Northern and Western Euro-
pean Ancestry) population in the HapMap project [29] for
comparison. The haplotype block structure in the Hap-
Map population was used to construct haplotypes for
individual subjects. Subjects were assigned haplotype
pairs and the posterior probabilities of those haplotype
pairs were determined using haplo.em in the haplo.stats
package of R. If haplotypes had less than five counts, they
were recoded to the closest haplotype. If the closest hap-
lotype differed by more than one SNP, data related to the
minor haplotype were deleted. All further analyses were
weighted by the posterior probability of that particular
haplotype pair. Additive, recessive, and dominant repre-
sentations for all haplotypes were examined in a forward
selection model building procedure where the criterion
for entrance into the model was P < 0.01.
Multivariate Genetic Model
A backwards selection linear regression was used to create
a multivariate model that potentially could include effects
for all genes that were significant in the univariate analy-
sis. To start the model selection procedure, the best fit uni-
variate model for each gene, either haplotype-based or
SNP-based, according to the Bayesian Information Crite-
rion [BIC, 30], was entered into the model. An exit crite-
rion of P > 0.01 was used in the model building process.
Multivariate Model With Covariates
A multivariate model was also created using the candidate
genes and the covariates shown in Additional file 1, Table
S2. A backwards selection model building process was
used, with a more conservative exit criterion of P > 0.001.Page 6 of 23
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Candidate Genes
Each candidate gene was tested for association with each
of the covariates that remained in the final multivariate
model. Each gene by covariate pair was tested independ-
ently. Genes were represented using their best fit univari-
ate model as described above. For the binary covariates, a
Fisher's exact test was used for association. For continuous
covariates, an ANOVA model was used for association. All
P-values were adjusted (within population) for multiple
comparisons using an FDR [31].
Results
Animal Studies
Alcohol Consumption by HXB/BXH RI Rat Strains
Figure 1 shows the average daily alcohol consumption for
each of the HXB/BXH RI strains and the two progenitor
strains. Alcohol consumption varied among strains, and it
was calculated that 49% of the variance could be attrib-
uted to strain (genetic variance).
Behavioral QTL
Four genomic regions were identified as having significant
or suggestive associations with alcohol consumption in
the HXB/BXH rats (Figure 2). The most significant marker
was on chromosome 1 at 224.7 Mb, and it had a LOD
score of 4.02 (empirical P-value = 0.05). This particular
QTL and two other regions had multiple adjacent markers
with a LOD score above 2. The bQTL region in each case
was extended 10 Mb on either side of the adjacent markers
which had LOD scores above 2.0 (Figure 2).
Gene Expression Data and Filtering of Gene Expression 
Data from HXB/BXH RI Strains
Quality Control and Normalization
After quality control http://Phenogen.UCHSC.edu, 121
arrays remained from the 25 strains used for the alcohol
consumption and gene expression correlation analysis.
We eliminated 497 control probes from further analysis
along with a total of 31,379 (<1%) individual expression
values due to quality control flags. In addition 45,722
expression values (1% of remaining values) were changed
to 0.00001 because original (local background-corrected)
spectroscopically derived values were less than 0. A total
of 33,849 probes on each of the 121 arrays were included
in the further analysis (filtering and correlation analysis).
Strain Distribution of Average Daily Ethanol ConsumptionFigure 1
Strain Distribution of Average Daily Ethanol Consumption. Rats were given 10% ethanol as their only choice of fluid 
for one week (week 0). For the next seven weeks, rats were given a choice of two bottles, one with water and one with a 10% 
ethanol solution. The data shown are mean ± SEM of average daily ethanol consumption (g/kg body weight) during the second 
week of the two-bottle choice paradigm.Page 7 of 23
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As noted in methods, a number of filters were used to
identify a list of potential candidate genes for alcohol pref-
erence in the HXB/BXH RI rats. Starting with the quality
controlled, normalized dataset, we initially determined
probes that could be matched with exonic regions of the
rat genome (or with a homologous human or mouse
sequence). There are 14,622 unique rat RefSeq DNA IDs
specified by the UCSC Genome Browser. Of these, 8,433
genes (10,162 probes) are included on the CodeLink
Whole Genome Rat Array. We identified 4,966 additional
probes on the CodeLink array that were associated with
either a human or mouse homolog gene (RefSeq DNA ID)
whose sequence matched an area of the rat genome. Of
these 15,128 probes, 12,466 (82%) were present (by our
criteria) in the brain samples that we analyzed. Significant
or suggestive eQTLs could be identified for 2,164 probes
(17%), and, of these, 378 probes had an eQTL that over-
lapped one of the bQTLs for alcohol consumption in
these rats. Transcripts with eQTLs that overlap bQTLs were
considered to represent likely candidate genes for the
alcohol consumption behavior [2]. The heritability filter
was used to insure that the expression levels of genes in
the candidate gene list had a high heritability, and 308
probes met the criterion of a broad sense heritability ≥ 0.5.
We also applied a filter based on detectable levels of
expression in the rat brains. Only transcripts that were
expressed in brains of ≥ 50% of the individual samples
were included. Although this choice is arbitrary, we did
not wish to include genes with low or undetectable levels
of brain expression in a large number of strains, as such
transcripts could produce unreliable results. This filter was
passed by 304 probes. The final filter was correlation of
probe expression with alcohol consumption. By initially
applying all of the previous filters, the risk of false posi-
tives in this correlation step was reduced. Of the 304 start-
ing probes, 20 had a significant (P < 0.05) correlation
with alcohol consumption in the HXB/BXH RI rat strains.
These probes are listed in Table 1.
The chromosomal locations, as well as the location of the
bQTLs and eQTLs for the 20 probes, are shown in Table 1.
Nine of the candidate genes were posited to be cis-regu-
lated, i.e., the chromosomal location of the gene is within
5 Mb of the eQTL location. The expression of the rest of
the candidate genes was posited to be regulated from an
area in the genome distant from the physical location of
the gene (trans-regulation). The expression of seven of the
trans-regulated genes was controlled from an eQTL on
chromosome 6. This finding suggests the possibility that
there is, for example, a polymorphic gene coding for a
transcription factor within this eQTL region, and that this
transcription factor contributes to the regulation of the
expression of all seven of the candidate genes. Although
18 putative transcription factor genes could be identified
in the eQTL region on chromosome 6 (see Additional file
1, Table S1), there is not sufficient information available
on the exact nature of the binding sites for these transcrip-
QTLs for Alcohol Consumption by HXB/BXH RI Rat StrainsFigure 2
QTLs for Alcohol Consumption by HXB/BXH RI Rat Strains. Behavioral QTLs (bQTLs) were calculated using the data 
shown in Figure 1. Individual values were not included if they were more than two standard deviations from the strain mean. 
The STAR Consortium SNP markers (The STAR Consortium, 2008) were used for this analysis. There were 21 RI strains and 
the two progenitor strains that had both alcohol consumption and SNP data. Strain means for alcohol consumption were used 
in a marker regression QTL analysis, which was conducted using the R/qtl package in R. The 20 Mb region around the sugges-
tive markers was used as the bQTL interval shown.
QTLs for alcohol consumption:
Chr 1: 159-194 Mb
Chr 1: 213-238 Mb
Chr 6: 33-53 Mb
Chr 12: 25-46 MbPage 8 of 23
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Gene 
Symbol
Gene 
Description
Gene 
Location 
Chr(Mb)
eQTL 
Location 
Chr(Mb)
eQTL Mb 
Range
eQTL LOD 
(p-value)
bQTL 
Location 
Chr(Mb)
Correlation 
Coefficient 
(p-value)
Broad Sense 
Heritability
Percent 
Present
Cckbr cholecystokini
n B receptor
1 (163.17) 1 (168.95) 139.73-179.97 6.3 (<0.001) 1 (159-194) 0.61 (0.0023) 0.82 100%
Coq7 demethyl-Q 7 
(Coenzyme q 
(ubiquinone) 
biosynthetic 
enzyme 
(DHPB 
methyltransfer
ase) 7)
1 (176.76) 1 (177.64) 152.25-179.75 9.0 (<0.001) 0.55 (0.0059) 0.93 100%
Fgfr2 fibroblast 
growth factor 
receptor 2 
isoform c
1 (189.48) 1 (184.63) 173.38-184.63 20.7 (<0.001) 0.58 (0.0029) 0.99 93%
Ptpre protein 
tyrosine 
phosphatase 
receptor type 
E
1 (195.16) 1 (195.13) 184.63-196.57 13.1 (<0.001) -0.43 (0.0348) 0.95 100%
Abat 4-
aminobutyrate 
aminotransfer
ase
10 (7.04) 1 (132.04) 12.84-249.11 4.2 (0.027) -0.51 (0.0267) 0.56 100%
Tpst1 tyrosylprotein 
sulfotransferas
e 1 (predicted)
12 (27.59) 1 (15.55) 9.02-205.67 3.1 (0.096) 0.51 (0.0265) 0.54 99%
Tmem2 transmembran
e protein 2
1 (225.04) 1 (223.19) 39.64-254.91 3.7 (0.065) 1 (213-238) 0.53 (0.0095) 0.85 100%
Mboat2 membrane 
bound O-
acyltransferase 
domain
6 (42.49) 6 (38.84) 18.53-131.90 3.5 (0.072) 6 (33-53) 0.43 (0.0455) 0.73 100%
Dynlrb1 dynein light 
chain 
roadblock-
type 1
3 (145.72) 6 (38.84) 18.53-115.00 3.6 (0.095) 0.44 (0.0456) 0.66 100%
Tnk2 tyrosine 
kinase, no-
receptor, 2
11 (69.93) 6 (25.68) 0.27-38.84 4.0 (0.010) -0.50 (0.0212) 0.68 100%
Nek3 NIMA (never 
in mitosis gene 
a)-related 
expressed
16 (74.52) 6 (37.98) 25.56-37.98 4.1 (0.008) -0.43 (0.0499) 0.69 97%
Afap1l1 actin filament 
associated 
protein 1-like 
1
18 (57.71) 6 (33.80) 25.68-50.93 3.3 (0.090) 0.49 (0.0227) 0.74 100%
Mc4r melanocortin 
4 receptor
18 (63.39) 6 (33.80) 33.80-50.93 3.7 (0.006) 0.46 (0.0417) 0.59 96%
Tubb6 tubulin beta 6 18 (63.92) 6 (33.80) 33.80-124.56 3.2 (0.097) 0.47 (0.0344) 0.63 98%
Spire1 spire homolog 
1
18 (64.02) 6 (33.80) 18.53-98.70 3.4 (0.025) 0.53 (0.0109) 0.77 100%
Mogat2 monoacyglyce
rol O-
acyltransferase 
2
1 (156.52) 12 (34.31) 29.92-38.52 3.5 (0.028) 12 (25-46) -0.45 (0.0353) 0.78 98%Page 9 of 23
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overrepresented in the promoter regions of the trans-regu-
lated genes. Table 1 also shows the correlation coefficients
for the correlation with alcohol consumption, and the
results of the heritability and expression level filters. The
expression levels of 13 of these probes were positively cor-
related with alcohol consumption, and expression levels
of seven were negatively correlated.
The transcript that explains the greatest proportion of
genetic variance in alcohol consumption in the HXB/BXH
RI strains is P2rx4 (r2 = 0.39, model P = .0009). When we
performed a forward stepwise regression analysis to deter-
mine a multivariate model for alcohol consumption, the
final model contained P2rx4 and Tmem2. The model
explained 57% of the genetic variance among strain
means for alcohol consumption.
Replication Study of Candidate Gene Expression in HXB/BXH Rat 
Strains
The results obtained using the CodeLink arrays were
assessed using a different gene expression measurement
platform. The analysis of the Affymetrix Array data for the
expression levels of the candidate genes in brains of rats
from two HXB/BXH strains are shown in Table 2. These
two strains were chosen based on their differences in vol-
untary alcohol consumption (see Figure 1) and their dif-
ferences in brain candidate gene expression levels
determined using the CodeLink arrays. Table 2 includes
data from the CodeLink and Affymetrix arrays for these
two strains to allow comparisons. In evaluating the repli-
cability of results, it is necessary to keep in mind that even
though the candidate genes displayed a significant corre-
lation with alcohol consumption when all RI strains were
considered, not all of the candidate genes (based on
CodeLink results) displayed significantly different expres-
sion levels in these two particular strains. However, the
expression differences in these strains were all in the same
direction as the overall correlation. Therefore, in compar-
ing to the results for the Affymetrix arrays, we took into
account both the significance and direction of expression
differences. Three candidate genes displayed significant
differences in expression, in the same direction, using
both arrays: Afap1l1, Cckbr and P2rx4. Another six candi-
date genes showed significant differences using CodeLink
arrays, and the same direction of differences on the
Affymetrix arrays (Tnk2, Tubb6, Ptpre, Mogat2, Nek3 and
Tmem2). Three of the candidate genes did not show signif-
icant differences in expression using the CodeLink arrays,
but either did show a significant difference in expression
levels in the same direction (Mc4r), or showed non-signif-
icant differences in expression in the same direction using
the Affymetrix arrays (F2rl1, Abat). Based on this analysis,
we placed more confidence in these 12 of the 20 original
candidate genes. The rest of the candidate genes did not
show significantly different levels of expression using the
Affymetrix arrays, and showed differences in expression in
opposite directions on the two platforms. Since the
expression values obtained with CodeLink arrays are
based on one probe, while the expression values from the
Affymetrix arrays represent a summary from multiple
probes, spread throughout each gene, we also compared
results for probes on the Affymetrix arrays that correspond
in location to the probes on the CodeLink arrays. In most
cases, the results for Affymetrix individual probes and
probesets were the same. For Tnk2, the result from the
individual probe on the Affymetrix array indicated a sig-
nificantly different expression level between strains in the
same direction as had been determined using the Code-
Link array between the tested strains. We have limited our
F2rl1 proteinase-
activated 
receptor-2 G 
protein 
coupled
2 (25.89) 12 (38.52) 36.18-43.30 2.8 (0.059) 0.53 (0.0224) 0.52 52%
P2rx4 P2X 
purinoceptor 
4 
(ATP 
receptor)
12 (34.94) 12 (34.50) 13.40-34.50 5.1 (0.003) -0.70 (0.0004) 0.80 100%
Rab35 RAB35 
member RAS 
oncogene 
family
12 (42.23) 12 (41.98) 38.21-43.30 9.0 (<0.001) 0.45 (0.0296) 0.91 100%
Pop5 processing of 
precursor 5 
ribonuclease 
P/MRP
12 (42.64) 12 (41.98) 36.18-43.30 4.4 (0.025) -0.54 (0.0125) 0.68 100%
All transcripts listed displayed an eQTL/bQTL overlap, showed a significant correlation with alcohol consumption, and passed the filters for heritability and detectability of 
expression.
Table 1: Candidate Genes for Alcohol Consumption by HXB/BXH RI Rats. (Continued)Page 10 of 23
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(same direction of differential expression) using both
CodeLink and Affymetrix arrays (Table 2).
Human Association Study
Outcome
Of the original 606 subjects in the WHO/ISBRA data from
Montreal, 545 were self-reported Caucasian. Alcohol con-
sumption in the Montreal population ranged from
Table 2: Replication Study of Candidate Genes
Affymetrix Results CodeLink Results
Gene Symbol HXB23 HXB26 Ratio p-value HXB23 HXB26 Ratio p-value Match Direction
Afap1l1 6.44 6.69 0.84 0.0344 1.22 1.58 0.78 0.0199 Yes
Cckbr 7.92 8.31 0.76 0.0063 2.25 2.84 0.66 0.0110 Yes
P2rx4 8.45 7.52 1.90 0.0122 2.53 1.50 2.04 <.0001 Yes
Tnk2 8.80 8.68 1.09 0.3473 4.17 3.59 1.50 0.0214 Yes
Tubb6 6.92 7.00 0.94 0.5960 0.30 0.69 0.76 0.0400 Yes
Ptpre 7.70 7.63 1.05 0.2589 1.93 0.77 2.23 <.0001 Yes
Mogat2 5.26 5.10 1.12 0.3124 0.63 -0.63 2.39 0.0005 Yes
Nek3 6.05 5.90 1.10 0.1681 -0.36 -0.54 1.13 0.0388 Yes
Tmem2 7.25 7.32 0.95 0.3860 2.47 2.82 0.78 0.0086 Yes
Mc4r 6.01 5.82 0.87 0.0360 -0.39 -0.26 0.91 0.2058 Yes
F2rl1 6.16 6.26 0.94 0.3674 -2.10 -1.72 0.77 0.3943 Yes
Abat 10.52 10.35 1.13 0.0669 4.71 4.66 1.04 0.4464 Yes
Mboat2 8.73 8.46 1.21 0.0797 0.95 1.31 0.78 0.0051 No
Coq7 8.22 8.02 1.15 0.2095 2.60 3.76 0.45 <.0001 No
Dynlrb1 11.27 11.23 1.03 0.7064 5.96 6.00 0.97 0.4726 No
Tpst1 7.70 7.56 1.10 0.1642 3.12 3.77 0.64 0.0004 No
Fgfr2 9.44 9.41 1.02 0.7038 -1.10 4.25 0.02 <.0001 No
Pop5 7.53 7.55 0.98 0.9056 2.58 2.45 1.09 0.1509 No
Rab35 8.91 8.87 1.03 0.7719 4.18 4.28 0.93 0.0107 No
Spire1 9.78 9.74 1.03 0.3554 1.50 3.26 0.30 <.0001 No
Expression levels of the identified candidate genes were determined in brains (n = 5 per strain) of rats from two of the RI strains, HXB RI 26 (high 
alcohol consumption) and HXB RI 23 (low alcohol consumption) using CodeLink Rat Whole Genome Bioarrays and Affymetrix GeneChip Rat 
Gene 1.0ST arrays. These strains were chosen because the expression levels of all candidate genes (on CodeLink arrays) that were significantly 
correlated with alcohol consumption when all the RI strains were analyzed, showed an appropriate direction of differential expression in these two 
strains compared to the correlation analysis, even if the difference in expression between these 2 particular strains was not statistically significant. 
Details on analysis, normalization and statistical comparisons are provided in the text. Values represent mean of the log base 2 transformed 
expression data. "Ratio" is the HXB23/HXB26 ratio of the unlogged intensity values. P values are from the two-sample t-test, and "match direction" 
refers to the comparison between the two array experiments.Page 11 of 23
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g/kg/day; see Additional file 1, Figure S1). Likewise, in the
Sydney population, 242 of the original 285 subjects were
Caucasian and alcohol consumption ranged from
abstainers (0 g/kg/day) to heavy drinkers (maximum, 7.3
g/kg/day; see Additional file 1, Figure S1). Other covari-
ates, and demographic characteristics, were comparable
between the two populations with the exception of gender
because only male subjects were recruited in Sydney
(Additional file 1, Tables S2 and S3). For the purpose of
comparability, we report results from only the male Cau-
casian subjects (n = 280) from the Montreal population.
Quality Control
Out of the 1,350 gene-related SNPs, 98 SNPs were not
genotyped in any of the Montreal subjects (98 in Sydney
subjects) and 88 were not informative across the Montreal
sample (49 in the Sydney sample). Further evaluation of
the remaining SNPs resulted in 121 SNPs being elimi-
nated because they were not in Hardy-Weinberg equilib-
rium (HWE) in the Montreal sample (156 SNPs in the
Sydney sample) (FDR<0.01). An additional 203 SNPs
were eliminated in the Montreal sample (203 in Sydney)
that had a minor allele frequency (MAF) that was less than
5% (46 SNPs in the Montreal population (79 in Sydney)
did not meet HWE and had a MAF<5%). In addition, 110
subjects from Montreal and 61 subjects from Sydney were
eliminated for having a call rate that was less than 80%,
based on the criteria described in Hodgkinson et al. [14].
These exclusion criteria left 840 SNPs on 435 subjects for
analysis in the Montreal population (220 males) and 845
SNPs on 181 subjects in the Sydney population.
Population Stratification
There was no evidence for population stratification at
each site with respect to the outcome, i.e., alcohol con-
sumption (chi-square = 344, df = 352, P-value = 0.62).
However, there was substantial evidence for genetic differ-
ence between the population gathered in Sydney vs the
population from Montreal (chi-square = 318, df = 176, P-
value = 3.1 × 10-10). Because there was such strong evi-
dence for genetic differences between the populations, the
two populations were analyzed separately.
Genetic and Phenotypic Associations with Alcohol Consumption
Table 3 shows the SNPs that were significantly associated
with alcohol consumption in the univariate analysis. In
the Montreal population, SNPs representing two unique
genes (GAD1, MPDZ) were significantly associated with
alcohol consumption. Although the significant SNP in
MPDZ only reached statistical significance in the dataset
that combined both males and females, its FDR was 0.09
in Montreal males. For consistency, all further analyses in
the Montreal population were only conducted on male
subjects. In the Sydney population, SNPs representing
four unique genes (CHRM5, GABRB2, MAPK1, PPP1R1B)
were associated with alcohol consumption.
We determined the haplotype block that contained each
significant SNP. For GAD1 in the Montreal sample, three
SNPs significantly associated with alcohol consumption
were located within the same known haplotype block
(Additional file 1, Figure S2). Haplotypes and individual
SNPs were evaluated for their association with alcohol
consumption to determine the best fit model for each
gene.
The final genetic multivariate model for Montreal male
subjects included the recessive effect of haplotype 2 (see
Additional file 1, Table S4) in MPDZ and the SNP geno-
type effect for rs701492 in GAD1 (Table 4). In combina-
tion, these two genetic factors explained 16% of the total
variance in alcohol consumption. For the subjects from
Sydney, three of the candidate genes were represented by
SNPs in the final genetic multivariate model (Table 4). For
the fourth candidate gene, MAPK1, the best fit to the data
was a model with both an additive and dominant compo-
nent for haplotype 3 (see Additional file 1, Table S4);
however, this gene was not included in the final genetic
multivariate model.
We also analyzed the relationship of phenotypic charac-
teristics with alcohol consumption levels by males in Syd-
ney and Montreal. As expected, our data showed that
alcohol consumption was positively correlated with alco-
hol dependence in both populations (Additional file 1,
Figure S3). The multivariate model with covariates for the
Sydney population included alcohol abuse and the diag-
nosis of alcohol dependence (DSM-IV) (Table 4). In the
population from Montreal, the multivariate model with
covariates included a diagnosis of major depression and a
family history of depression, as well as alcohol abuse and
dependence (Table 4). In both populations the models
including genetic and phenotypic characteristics
accounted for 62% of the variance in alcohol consump-
tion. Our further analysis indicated that none of the gen-
otypes or haplotypes that were found to be significantly
associated with alcohol consumption were significantly
associated with alcohol abuse or alcohol dependence in
either population (FDR >0.05). In fact, we found none of
the SNPs represented on the "addiction array" to be signif-
icantly associated with DSM-IV alcohol dependence in
either the Sydney or Montreal populations (FDR >0.05).
A caveat to keep in mind is that the sample sizes may not
have provided enough power to allow us to detect associ-
ations using the binary outcomes of alcohol dependence
or abuse.Page 12 of 23
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The reasons for differential intake of ethanol by individu-
als in a population, be it humans or other animals, have
been the subject of an immense amount of research. The
current dogma posits that both environmental and
genetic factors contribute to individual differences in alco-
hol consumption [32,33]. What is sometimes confusing
about the literature on alcohol consumption is the lack of
discrimination between alcohol consumption in non-
dependent vs alcohol-dependent individuals [34]. The
DSM IV and ICD-10 criteria for alcohol dependence focus
intensively on dichotomizing alcohol drinking behavior
in dependent and nondependent individuals [35,36] and
several recent reviews by authors of this current work [37],
and others [9], have detailed evidence and hypotheses
regarding the progression of events which transform the
non-dependent alcohol intake phenotype to the alcohol-
dependent alcohol intake phenotype.
Epidemiologic studies do indicate that the higher the lev-
els of alcohol intake by an individual, the higher is the
propensity for an individual to become alcohol depend-
ent [38]. In this regard, high levels of alcohol intake
become a risk factor for transition to alcohol dependence,
but there is no a priori reason to assume that the genetic
factors that may be responsible for modulating an indi-
vidual's non-dependent levels of alcohol consumption
are the same factors that predispose or protect an individ-
ual from becoming dependent. In other words, a genetic
relationship between the propensity for high alcohol
intake and the propensity for becoming alcohol depend-
ent has not been demonstrated. In fact, one can interpret
some of the data collected with mice to show a dissocia-
tion between a propensity for high alcohol preference and
propensity for physical dependence. C57BL/6 mice are a
genetically inbred strain that has been demonstrated to
have one of the highest levels of alcohol preference, but
these mice have a low propensity to develop alcohol
dependence (exemplified by signs of CNS withdrawal
Table 3: Genetic (SNP) Associations with Alcohol Consumption: WHO/ISBRA Subjects
refSNP ID Location Within 
Gene
Chr Basepair minor allele/major 
allelea
MAF 
(Males/Females)
unadjusted p-value FDR
MONTREAL
rs2241165 intronic region of GAD1 2 171386625 C/T 0.25/0.23 0.0001 0.0400
rs701492 intronic or downstream 
region of GAD1
2 171410726 T/C 0.31/0.31 <0.0001 0.0018
rs7578661 intronic region of GAD1 2 171423379 G/C 0.31/0.31 <0.0001 0.0018
rs1389752 intronic region of MPDZ 9 13225287 A/T 0.14/0.15 <0.0001b 0.0130b
SYDNEY
rs8030094 intronic region of 
CHRM5
15 32124174 A/G 0.18/NA 0.0002 0.0326
rs10051667 intronic region of 
GABRB2
5 160830906 C/T 0.09/NA <0.0001 0.0110
rs9607272 intronic region of 
MAPK1 and TUBA8c
22 20466398 G/T 0.19/NA <0.0001 0.0062
rs879606 upstream region of 
PPP1R1B
17 35035375 A/G 0.13/NA <0.0001 0.0062
Significant results from univariate association analysis with alcohol consumption. Shown are the eight SNPs that showed a significant (FDR<0.05) 
association with alcohol consumption (g/kg/day) in a genotype model.
aMinor and major allele designation is according to Ensembl release 50.
bThis SNP was significant when both genders are combined; in male subjects, the FDR for this SNP was 0.09. All other SNPs shown were significant 
when males only were tested.
cThe localization of this SNP is ambiguous. Its presence in MAPK1 and the overlapping gene, TUBA8 (tubulin alpha 8) is of particular interest, given 
the findings of differences in expression of cytoskeletal genes in the HXB/BXH rat strains.Page 13 of 23
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that the phenotype we are investigating in this paper is
non-dependent alcohol intake.
What emanates as a conclusion from our genetical
genomic/phenomic approach for the search for "candi-
date genes" that influence non-dependent alcohol intake
is that a group of genes/gene products that can be linked
to systems which, in the rat (and human), control appetite
and satiety, play an important role in variations in the
non-dependent alcohol intake phenotype (see 5). It is of
interest that our earlier work, which involved a meta-anal-
ysis of data from recombinant inbred mice, selectively
bred mice and a large panel of inbred mice, indicated that
orosensory systems in the mice are critically involved in
alcohol selection in a two-bottle choice experimental
design [2]. Our two studies, taken together with a number
of prior studies [41], indicate that alcohol selection by
rodents involves the sensory and caloric information
transduction systems dealing with the recognition, and
the satiating and rewarding properties of foodstuffs. Etha-
nol, unlike other psychoactive drugs, has significant
caloric value (seven cal/gm) and these calories have been
clearly shown to have relevance to an organism's energy
status [42].
Figure 3 illustrates that most of the candidate genes that
we identified can be related within a neurobiological
pathway that was constructed based on analysis of the lit-
erature. Many of the candidate genes identified in this
study code for products (protein) that have been impli-
cated in regulation of feeding and energy metabolism. For
example, the cholecystokinin 2 (CCK2) receptor is
expressed in hypothalamic regions such as the paraven-
tricular nucleus (PVN), which contains the circuitry neces-
sary for maintaining energy homeostasis (food intake vs
energy expenditure). CCK released from the gut acts as a
"satiety hormone" [43], and can activate neurons in vari-
ous hypothalamic regions [44]. The melanocortin 4 recep-
tor (Mc4r) is also expressed in the hypothalamic regions
that regulate energy metabolism, and activation of these
receptors by the endogenous agonist, MSH, also inhibits
food intake. It has been suggested that these actions
involve changes in GABA release from hypothalamic
interneurons [45,46]. Both Mc4r and CCK2R are
expressed at higher levels in animals that consume higher
amounts of alcohol, suggesting that these animals may
have an inherent propensity for reduced food intake and
lower energy expenditure.
However, animals and humans ingest food not only for
nourishment, but also for the rewarding properties of
food, and motivational mechanisms are important for
generating responses needed for food-seeking and con-
sumption behavior. The neuronal pathways and neuro-
transmitter substances that regulate food intake for energy
Table 4: Multivariate Models with Covariates for Alcohol Consumption
MONTREAL (r2 = 0.62)
Effect Estimate Standard Error t-statistic p-value
Intercept -0.59 0.13 -4.59 <.0001
recessive haplotype 2 - MPDZ 1.02 0.24 4.17 <.0001
rs701492 - GAD1 (AA) 0.70 0.10 6.94 <.0001
rs701492 - GAD1 (AB) -0.03 0.07 -0.42 0.6714
rs701492 - GAD1 (BB) referent
Age 0.01 0.00 4.50 <.0001
Alcohol dependence in past year 1.04 0.10 10.73 <.0001
Alcohol abuse in past year 0.73 0.10 7.67 <.0001
Family history of depression (1st degree relative) 0.50 0.09 5.45 <.0001
Familial depression and alcohol dependence* -0.85 0.14 -6.09 <.0001
Used medication other than antidepressants in last month 0.26 0.07 3.91 0.0001
SYDNEY (r2 = 0.62)
Effect Estimate Standard Error t-statistic p-value
Intercept 0.24 0.06 4.12 <.0001
CHRM5 (recessive) 2.10 0.35 5.95 <.0001
GABRB2 (dominant) 3.03 0.43 7.00 <.0001
PPP1R1B (recessive) 2.97 0.32 9.22 <.0001
Alcohol dependence in past year 0.58 0.11 5.06 <.0001
Alcohol abuse in past year 0.58 0.11 5.14 <.0001
Shown are the coefficients associated with the final multivariate models with covariates for alcohol consumption as outcome. Final models were 
chosen using a backward selection process with an exit criterion of p > 0.001.
* Familial depression is defined as major depression in the subject and in a first-degree relative.Page 14 of 23
(page number not for citation purposes)
BMC Biology 2009, 7:70 http://www.biomedcentral.com/1741-7007/7/70homeostasis, and for the rewarding properties of food, are
intimately connected but not identical. Particularly rele-
vant to our current studies are the hypothalamic nuclei
with connections to the ventral tegmental area (VTA) that
generate and carry information on hunger and satiety, and
initiate the cascade of events resulting in "wanting/liking"
food or other "rewards" [47,48]. Much of the hypotha-
lamic input to the VTA which provides information on the
energy status of the mammalian organism is initiated in
the arcuate nucleus of the hypothalamus and transmitted
via the lateral hypothalamus to the VTA dopaminergic
neurons. The transmitter substance that has been associ-
ated with stimulatory input from the lateral hypothala-
mus is orexin, which activates the dopaminergic neurons
of the VTA [49]. GABA neurons provide the major direct
inhibitory input to the dopaminergic neurons of the VTA,
but GABA neurons arising in the arcuate nucleus also pro-
vide inhibitory input to the orexin neurons residing in the
lateral hypothalamus [49]. Thus, GABAergic activity
related to food/energy requirements can generate inhibi-
tory influences on the VTA dopaminergic neuron firing
either directly or through inhibition of orexin signaling to
the VTA.
The products of many of the candidate genes identified in
this study can affect GABAergic neuronal activity. One of
the most studied systems in this regard, and one suggested
to link the homeostatic and reward pathways associated
with food intake [50], is the endocannabinoid system.
The endogenous agonists anandamide and 2-AG (2-ara-
chidonoyl glycerol) act primarily through presynaptic
cannabinoid 1 (CB1) receptors to inhibit GABA release
[51]. The endocannabinoid system in the hypothalamus
has been implicated in regulation of both food and etha-
nol intake [52,53]. 2-AG can act as an anterograde or ret-
rograde messenger to inhibit GABA release [54], and can
then be inactivated by hydrolysis by monoacylglycerol
lipase or fatty acid amide hydrolase [55]. More recently,
however, another group of enzymes has been proposed to
inactivate 2-AG, not by hydrolysis, but by conversion of 2-
AG to diacylglycerol. The enzyme carrying out this reac-
tion is the product of Mogat2 (also referred to as
Mgat2))[56]. Mogat2 mRNA was found to be expressed at
Table 5: Function of Replicated Candidate Gene Products
Correlation with Alcohol Consumption Gene Symbol Gene Name and Description
+ Mc4r Melanocortin 4 receptor; activation by melanocortin (MSH) decreases caloric 
intake. Mc4r localized on GABA neurons. Mc4r agonist reduced ethanol 
consumption in association with food consumption [45,65,116].
+ Cckbr Cholecystokinin 2 receptor; Cholecystokinin (CCK) is localized in some GABA 
interneurons, and activation of Cck2r can facilitate GABA release. CCK is a 
satiety hormone. Cck2r null mutants show low alcohol consumption [60,95,117].
- Mogat2
= MGAT2
Monoacylglycerol O-acyltransferase 2; esterase affecting mono- and di-
acylglycerol.
- Abat 4-aminobutyrate aminotransferase (GABA aminotransferase); GABA degrading 
enzyme.
- P2rx4 P2x purinoceptor 4; located on GABA neuron terminals in VTA and is a cation 
channel for Ca2+. Enhances GABA release by presynaptic action. Inhibited by 
ethanol [118].
- Ptpre Receptor type protein tyrosine phosphatase epsilon; inhibits voltage-gated K+ 
channels on GABA interneurons [62].
+ Afap1l1 Actin filament associated protein; interacts with dynamin, involved in endocytosis.
+ Tubb6 Tubulin B6; cytoplasmic dynein interacts with tubulin, involved in microtubule 
movement [79].
- Tnk2 Protein tyrosine kinase Ack; Cdc42-associated kinase, located pre and post 
synaptically; influences endocytosis [72].
+ F2rl1 Protease-activated receptor 2(PAR2); activates PI3-kinase, activation of Cdc42 
required. Increases Ca2+ signaling. In Glu and GABA neurons [75,76].Page 15 of 23
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resulting in a reduced rate of metabolism of 2-AG, leading
to greater inhibition of GABA release.
The cholecystokinin 2 (CCK2) receptor is expressed not
only in the hypothalamus, but also in other brain regions,
such as the VTA or amygdala, where it is localized presyn-
aptically on GABA neurons [57,58]. The activation of the
CCK2 receptor has been shown to promote action poten-
tial-induced GABA release in certain brain areas (e.g., hip-
pocampus) [59], but more recent data suggest that the
initial increase in GABA release produced by CCK via the
CCK2 receptors is followed by a reduction in GABA
release [60]. Our findings of higher levels of the mRNA for
the CCK2 receptor in high alcohol consuming rats could
be construed as another differential means of modulating
GABA release in low and high-drinking rats. Another can-
didate gene product, the P2X4 purinergic receptor (the
product of P2rx4), is also localized presynaptically on
GABA neuron terminals [61]. Activation of P2X4 receptors
on GABA terminals may increase GABA release [61]. Since
P2X4 receptor mRNA is expressed at lower levels in the
high alcohol-consuming animals, this again would point
to diminished levels of GABA release in such rats.
Candidate Genes from HXB/BXH RI Rat Strain Microarray Analysis Proposed for Presynaptic GABA Neuron Terminal and Postsynaptic N uronFigure 3
Candidate Genes from HXB/BXH RI Rat Strain Microarray Analysis Proposed for Presynaptic GABA Neuron 
Terminal and Postsynaptic Neuron. The identified candidate genes are indicated by rectangles. Presynaptic gene products 
are suggested to modulate GABA release, and postsynaptic gene products affect GABAA receptor localization and trafficking in 
VTA dopaminergic neurons.
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the excitability of GABA neurons and GABA release. Ptpre
encodes the receptor type protein tyrosine phosphatase
epsilon, which has been reported to dephosphorylate and
decrease the activity of the voltage-gated potassium chan-
nel, Kv2.1 [62]. The Kv2.1 channel is found on somata
and proximal dendrites of inhibitory (GABAergic)
interneurons [see [62]]. The expression of Ptpre is lower in
animals that consume higher amounts of alcohol, and if
this results in a lesser level of phosphatase activity and
higher levels of the channel activity, one would expect
lower excitability of GABAergic interneurons in these ani-
mals.
On the other hand, another of the candidate genes, Abat,
codes for the enzyme 4-aminobutyrate (GABA) ami-
notransferase, which degrades GABA. This gene is
expressed at lower levels in animals with higher ethanol
consumption, and this situation could contribute to
enhanced GABA levels in GABAergic synapses in the high
alcohol-consuming rats.
The effects on GABAergic activity described above could
contribute to a decreased hypothalamic GABAergic inhib-
itory effect on VTA dopaminergic activity in the high alco-
hol-consuming rats. Furthermore, the products of a
number of the candidate genes can more directly affect the
activity of midbrain dopamine neurons. MSH, adminis-
tered into the VTA, increases dopamine release in the
nucleus accumbens via actions on VTA melanocortin 4
receptors [63]. Interestingly, administration of a melano-
cortin 4 receptor agonist to mice (icv) reduced alcohol
drinking [64], and administration of a melanocortin 3/4
receptor agonist to alcohol-preferring rats reduced alcohol
intake in association with reduced food intake [65]. The
CCK2 receptor is also found in the VTA [57] and likely
responds to CCK release from GABAergic neurons synaps-
ing directly with dopaminergic cell bodies in this region.
Administration of CCK into the VTA results in increased
dopamine release in the nucleus accumbens, mediated by
activation of the CCK2 receptors in the VTA [57,66].
Taken together with the inherent differences in expression
of genes whose products influence GABA release, the
greater expression of the CCK2 and MC4 receptors, if it
occurs in the VTA of the high alcohol consuming animals,
generates a picture of lower GABAergic inhibitory tone
and an increased propensity for direct dopaminergic neu-
ron activation in the VTA by MSH and CCK.
Recent work has shown that the quantities of ethanol con-
sumed by rats in a two-bottle choice paradigm, can, in
fact, enhance the electrophysiological activity of VTA
dopaminergic neurons [67]. What is unclear about such
studies is whether these effects of ethanol are direct or
indirect, through modulation of transmitters influencing
dopamine neuron firing. For example, acutely, ethanol
inhibits the function of the P2X4 receptor [68], and this
action may reduce the presynaptic function of the P2X4
receptor and reduce GABA release, thus disinhibiting
dopaminergic activity. Xiao and Ye [69] have also
reported that ethanol can acutely inhibit GABAergic neu-
ron activity in the VTA via other indirect mechanisms,
while enhancing such activity in other brain areas. These
actions of ethanol in the VTA would tend to disinhibit
dopaminergic neuron activity and synergize with the
inherently lower GABAergic tone suggested by our studies.
Another intriguing aspect of our candidate gene list is the
presence of a number of genes coding for products that
can affect postsynaptic aspects of GABA receptor traffick-
ing. These candidate genes and gene products are related
to rho GTPases, which affect the cytoskeleton, membrane
trafficking and cell adhesion through their regulation of
actin dynamics. For example, Cdc42 is a member of the
rho GTPase family that can stimulate actin polymeriza-
tion, affecting specific steps of vesicle trafficking such as
those involved in endocytosis [70]. Cdc42 can be acti-
vated by a protein called collybistin, which is a gephyrin-
binding protein [70]. Gephyrin is a scaffolding protein for
GABAA and glycine receptors [71], and these interactions
provide support for a specific role for Cdc42 in clustering
and trafficking of GABAA receptors.
Two of the candidate genes that we identified are Cdc42-
associated proteins. Tnk2 codes for a cytosolic non-recep-
tor tyrosine kinase, also known as Ack (activated Cdc42-
associated tyrosine kinase). This kinase has been identi-
fied as a downstream effector of Cdc42 which is impor-
tant for regulation of receptor degradation via endocytic
mechanisms [72]. It is widely expressed in brain, includ-
ing various nuclei of the mesencephalon [73]. F2rl1 codes
for a protease-activated receptor known as Par2. This G
protein-coupled receptor is also widely expressed in brain,
including relatively high expression in amygdala, and is
found in the soma and dendrites of GABAergic and gluta-
matergic neurons [74,75]. Par2 agonists activate several
cell signaling molecules, including phosphoinositide 3-
kinase. This latter activity requires Cdc42 activation by
Par2 [76]. The negative association of the expression of
Ack with alcohol preference, and the positive association
of Par2 expression, could enhance the endocytic recycling
process associated with Cdc42-mediated actin polymeri-
zation in the animals that consume higher amounts of
alcohol, leading to more rapid GABA receptor desensitiza-
tion.
The products of some other candidate genes are associated
with actin organization and microtubule activity, which is
also important for the trafficking of receptors and other
proteins. Afap1l1 codes for an actin filament associatedPage 17 of 23
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lated with alcohol consumption. Microtubules are
involved not only in receptor transport, but also in the
movement of gephyrin to and from the synaptic plasma
membrane [77]. Dynein is a microtubule motor that par-
ticipates in axonal transport of neurofilaments [78], and
that interacts with beta tubulin [79], the protein product
of another of the candidate genes, Tubb6. The expression
of all of the above-mentioned candidate genes is associ-
ated positively with alcohol consumption in the RI rat
strains, supporting the postulate that there may be
enhanced GABAA receptor trafficking (endocytosis), in the
brains of animals that have a propensity to consume more
alcohol.
Overall, our analysis of the functional pathways defined
by the identification of the candidate genes in the HXB/
BXH rat strains focuses attention on GABAergic and
dopaminergic activity that may set a tone that predisposes
to (or against) voluntary alcohol consumption. We are
proposing that, in rats, a lower inherent GABAergic tone
generated by reduction in presynaptic release and a more
responsive GABA receptor desensitization system predis-
poses to higher alcohol consumption in a free choice
experimental paradigm. There are numerous studies
showing that administration of agonists or antagonists of
GABA or dopamine receptors can alter alcohol consump-
tion or self-administration by rats [e.g., [80-90]].
Although we have focused attention on neuronal systems
which mediate the animals' recognition of the energy sta-
tus of the body and the rewarding properties of caloric
substances, it should be clearly stated that the candidate
genes we identified, and their products, do play important
roles in other anatomically-defined neural systems. A case
in point may be that dopaminergic neurons which inner-
vate the dorsal striatum (cell bodies in the substantia
nigra) may have as much to do with appetitive behavior
as the systems we describe innervating the nucleus
accumbens from the A10 nucleus (VTA) [91]. Another
area of brain where a number of the products of the can-
didate genes that we identified interact is the amygdala.
For instance, Mc4r is expressed in several nuclei of the
amygdala and in the bed nucleus of the stria terminalis
[92,93]. Studies with melanocortin 4 receptor null mutant
mice showed that restoration of the receptor in a popula-
tion of amygdala neurons reduced food intake [94], simi-
lar to the effect of activation of this receptor in
hypothalamus. Cckbr is expressed in the amygdala as well,
and CCK increases GABA release in amygdala via the
CCK2 receptor [95]. Higher levels of GABA release in the
amygdala may set a tone that predisposes to higher alco-
hol consumption, given the finding that delivery of
GABAA receptor antagonists to the amygdala reduced eth-
anol self-administration [81]. The endocannabinoid sys-
tem can also interact with the CCK system in the
amygdala, as well as modulating GABA release in this area
of brain. CB1 receptor agonists inhibit the release of CCK
from GABAergic neurons and Chhatwal et al. [96] have
shown that the effects of cannabinoids on the extinction
of conditioned fear responses are mediated through CCK2
receptors. Clearly the neuronal systems that affect condi-
tioned fear (anxiety) responses are also involved with
appetitive and reward pathways [97,98].
The ultimate goal of genetic studies using animal models
of alcohol consumption is to identify candidate genes that
influence a human's level of alcohol consumption. It
should be stressed at this point, that the phenotype we uti-
lized for our genetic association studies with humans was
also the quantitative measure of alcohol intake. This phe-
notype was chosen to allow proper comparison with our
studies with the rats. We also performed a separate analy-
sis of the genetic association of the phenotype of alcohol
dependence defined by both DSM IV and ICD-10 criteria
with the panel of 1,350 SNP marker included on the
"Addiction Array" [14]. The polymorphisms that we
found to be associated with the quantitative alcohol con-
sumption phenotype in human populations, identified
genes whose products are involved in the pathways deter-
mined from our studies of differential levels of alcohol
intake by the panel of recombinant inbred rats. Particu-
larly evident were components of the GABAergic signaling
pathway, including the β2 subunit of the GABAA receptor
in the Sydney population, and the GABA synthetic
enzyme, GAD1, as well as the MPDZ protein, which can
act as a scaffolding protein for the GABAB receptor [99], in
the Montreal population. MPDZ has previously been
linked to alcohol withdrawal seizure susceptibility in mice
[100], but not with levels of alcohol intake. The other
genes identified in the Sydney population have also been
linked to mesolimbic dopaminergic activity. CHRM5, the
M5 muscarinic cholinergic receptor subtype, localized on
VTA dopamine neurons, is thought to contribute to tonic
excitatory regulation of dopamine transmission [101]. As
noted earlier, our studies do indicate that the products of
the candidate genes predisposing high alcohol drinking
by rats can be linked to the modulation of VTA dopamine
neuron function. Additionally, muscarinic cholinergic
receptors in the VTA have been shown to play an impor-
tant role in alcohol selection by rats selectively bred (P
rats) for high alcohol intake [102]. PPP1R1B, also known
as DARPP-32, as well as MAP kinase (the product of
MAPK1 gene), are downstream targets of dopamine D1
receptors in the medium spiny neurons of the shell of the
nucleus accumbens and other brain areas receiving input
from the VTA. Although the "Addiction Array" SNPs did
not allow us to assess polymorphisms in a number of the
candidate genes identified in our studies with rats (e.g.,
Mc4r), it has been demonstrated that activation ofPage 18 of 23
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enhance dopamine D1 receptor-mediated cyclic AMP pro-
duction [103], and modulate the enzymatic activity of
DARPP-32. The Mc4r mRNA, which we found to be ele-
vated in brains of the alcohol-preferring rats, is reported to
be found in the nucleus accumbens, apparently in
medium spiny neurons, as well as in the VTA and hypoth-
alamus of humans [92,103].
The overall impression that is generated by cursorily
examining the results of our studies with rats and humans,
and our prior studies with mice, is that little evidence may
have been produced to indicate that identical genes or
gene products predispose free choice alcohol intake in
rodents or humans. What may be missed is the fact that
certain identical neurobiologic pathways have been iden-
tified in all of these investigations. In rodents, one can
posit that neurobiologic systems that participate in sens-
ing and transducing information about the rewarding or
aversive properties of foodstuffs play an important role in
oral consumption of ethanol in a free-choice paradigm.
Polymorphisms in the loci of genes involved in such an
appetitive pathway are also associated with quantitative
measures of alcohol intake in humans [104,105]. The
proposition that appetitive sensory systems and/or caloric
qualities of ethanol contribute to ethanol drinking by
rodents is not novel [41,106-108], but the identification
of such a relationship by an unbiased genetical genomic/
phenomic technique allows one to progress to examina-
tion of specific pathways and genetic mechanisms in
future studies.
Our results also cast some light on the influence of genetic
polymorphisms on levels of alcohol drinking vs alcohol
dependence in humans. Epidemiologic studies suggest a
strong correlation between levels of ethanol consumed
and the diagnosis of alcohol dependence [38], and alco-
hol intake has been taken by some as a surrogate (endo-
phenotype) for alcohol dependence [109]. In our study,
the polymorphisms that we found to be associated with
the level of alcohol consumption by humans continued to
have an influence in the multivariate model, even when
current alcohol dependence and alcohol abuse were
accounted for. This result, and the lack of association of
the candidate genes for levels of alcohol consumption,
with alcohol dependence/abuse in the same individuals,
suggest that the genetic factors that we identified as predis-
posing factors for alcohol consumption may have little
direct influence on alcohol dependence or abuse, but
would be important for generating the major risk factor
for dependence (i.e., high levels of alcohol consumption).
A recent genome-wide association study of alcohol
dependence in humans used genes identified by differen-
tial mRNA expression in alcohol-consuming rats as a
means of attempting to generate more credence in the
candidate genes with modest statistical support for associ-
ation with alcohol dependence in the analysis of the
human data [110]. Our studies would caution against
such an approach because genetic determinants for alco-
hol consumption by animals or humans may not be iden-
tical with genetic determinants of ethanol dependence.
This contention is also supported by QTL analysis of free-
choice alcohol consumption [111] and alcohol depend-
ence/withdrawal [112] in animals, and alcohol consump-
tion/alcohol dependence in humans [113-115]. The most
recent and instructive study in this regard is a study with
humans performed by Hansell et al. [105]. This study uti-
lized quantity/frequency measures of alcohol consump-
tion as a phenotype for a linkage study and found two
types of QTLs. The LOD scores for certain QTLs were
diminished if the primarily high level alcohol consumers
were utilized for analysis, and other QTLs were enhanced
if primarily high level consumers were used. What was
interesting is that the QTLs which were enhanced when
individuals with lower levels of alcohol consumption
were dropped from the analysis were those which, in
other studies, were related to "alcoholism" or alcohol
dependence. QTLs identified as significant and having
maximal LOD scores using the full range of alcohol con-
sumption in this population, were not in areas of the
human genome previously associated with alcohol
dependence. However, at least one such QTL was previ-
ously found by de Andrade et al. to be associated with the
number of drinks (on average) consumed by the subjects
collected in the COGA study [109].
Conclusion
The genetical genomics approach, in combination with
phenomics, is a powerful method for determination of
candidate genes that contribute to the predisposition to
alcohol consumption in rats. Informatics-based analysis
of the function of candidate gene products led to the con-
sideration that GABAergic function, and particularly
GABA release modulated by peptidergic, purinergic and
endogenous cannabinoid systems, as well as GABA recep-
tor trafficking, are important components of the genetic/
biochemical pathways that contribute to alcohol drink-
ing. Our results highlight the need to identify neuronal
signaling networks based on candidate genes, rather than
focusing on individual genes and gene products, when
attempting to understand the genetic basis of complex
behavioral traits. The comparison of rat and human
genetic contributors to the trait of alcohol consumption
suggested that one can extrapolate from pathways - not
necessarily specific genes - found in animals to begin to
elucidate cross-species similarities in the genetic basis of
behavior. Our results also emphasize the importance of
carefully defining phenotypes for genetical genomic
approaches; in this case, although high levels of alcoholPage 19 of 23
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dependence, the genetic factors that contribute to the full
range of alcohol consumption versus alcohol dependence
in humans are distinct.
Authors' contributions
BT planned and supervised all experiments, analyzed data
and drafted the manuscript. LS carried out eQTL and
bQTL analyses, correlation and all statistical analyses.
MPrintz provided data and tissue from the HXB/BXH rats,
participated in alcohol consumption studies, and ana-
lyzed alcohol consumption data. PF participated in HXB/
BXH rat alcohol consumption experiments and analyzed
data. CH performed studies using the addiction array. DG
supervised addiction array studies and analyzed data. GK
conceived, organized and supervised the HXB/BXH alco-
hol consumption studies. HNR organized and supervised
the HXB/BXH rat alcohol consumption studies and ana-
lyzed data. KK performed transcription factor and tran-
scription factor binding site analysis. RLB provided data
and tissue from P and NP rats. NH performed genotyping
of HXB/BXH RI strains. MH performed genotyping of
HXB/BXH RI strains. MPravenec provided tissue from
HXB/BXH rats. JM provided genotype data from HXB/
BXH RI rats. LL recruited subjects from Montreal and pro-
vided data and DNA. MD supervised studies and recruited
subjects in Montreal. KMC recruited subjects in Australia
and provided data and DNA. JW supervised human stud-
ies and recruited subjects in Australia. JS recruited subjects
in Australia and analyzed data. BG created questionnaire
for WHO/ISBRA study and generated algorithms for data
analysis. PLH analyzed microarray data and drafted man-
uscript. WHO/ISBRA Investigators are included as authors
on all studies using data from the WHO/ISBRA study, by
formal agreement.
Additional material
Acknowledgements
The authors thank Janet Hopkins for performance of assays for measuring 
mRNA levels; Ron Smith, Laura Breen and Joseph Gatewood for technical 
assistance with behavioral data collection and Dr. Samuel P. Hazen for 
expert advice on database management. WHO/ISBRA Study on State and 
Trait Markers of Alcoholism is an abbreviation for World Health Organiza-
tion/International Society for Biomedical Research on Alcoholism Study on 
State and Trait Markers of Alcohol Use and Dependence Investigators. This 
work was supported in part by NIAAA, NIH (AA013162 (BT); AA006420 
(GK); AA016649-INIA Project (PH); AA016663-INIA Project (BT); 
AA013522-INIA Project (RLB); AA013517-INIA Project (GK); AA-U01-
Developmental Grant - INIA Project (M Printz); AA16922 (KK)); NHLBI, 
NIH (HL35018 (M Printz)); Banbury Fund (BT); Pearson Center for Alco-
holism and Addiction Research (GK); National Health and Medical 
Research Council of Australia (WHO/ISBRA Sydney); La Fondation Jean 
Lapointe (WHO/ISBRA Montreal); National Health Research Development 
Program, Canada (WHO/ISBRA Montreal); Wellcome Trust Program for 
Cardiovascular Functional Genomics (JM); Ministry of Education of the 
Czech Republic (1M6837805002(M Pravenec)) and Howard Hughes Medi-
cal Institute (M Pravenec).
References
1. Drake TA, Schadt EE, Lusis AJ: Integrating genetic and gene
expression data: application to cardiovascular and metabolic
traits in mice.  Mamm Genome 2006, 17(6):466-479.
2. Tabakoff B, Saba L, Kechris K, Hu W, Bhave SV, Finn DA, Grahame
NJ, Hoffman PL: The genomic determinants of alcohol prefer-
ence in mice.  Mamm Genome 2008, 19(5):352-365.
3. Ganguly K, Stoeger T, Wesselkamper SC, Reinhard C, Sartor MA,
Medvedovic M, Tomlinson CR, Bolle I, Mason JM, Leikauf GD, et al.:
Candidate genes controlling pulmonary function in mice:
transcript profiling and predicted protein structure.  Physiol
Genomics 2007, 31(3):410-421.
4. Tabakoff B, Bhave SV, Hoffman PL: Selective breeding, quantita-
tive trait locus analysis, and gene arrays identify candidate
genes for complex drug-related behaviors.  J Neurosci 2003,
23(11):4491-4498.
5. Hu W, Saba L, Kechris K, Bhave SV, Hoffman PL, Tabakoff B:
Genomic insights into acute alcohol tolerance.  J Pharmacol Exp
Ther 2008, 326(3):792-800.
6. Feltenstein MW, See RE: The neurocircuitry of addiction: an
overview.  Br J Pharmacol 2008, 154(2):261-274.
7. Bell RL, Rodd ZA, Lumeng L, Murphy JM, McBride WJ: The alcohol-
preferring P rat and animal models of excessive alcohol
drinking.  Addict Biol 2006, 11(3-4):270-288.
8. Koob GF: Drugs of abuse: anatomy, pharmacology and func-
tion of reward pathways.  Trends Pharmacol Sci 1992,
13(5):177-184.
9. Kalivas PW, O'Brien C: Drug addiction as a pathology of staged
neuroplasticity.  Neuropsychopharmacology 2008, 33(1):166-180.
10. Kelley AE: Memory and addiction: shared neural circuitry and
molecular mechanisms.  Neuron 2004, 44(1):161-179.
11. Printz MP, Jirout M, Jaworski R, Alemayehu A, Kren V: Genetic
Models in Applied Physiology. HXB/BXH rat recombinant
inbred strain platform: a newly enhanced tool for cardiovas-
cular, behavioral, and developmental genetics and genomics.
J Appl Physiol 2003, 94(6):2510-2522.
12. The STAR Consortium: SNP and haplotype mapping for
genetic analysis in the rat.  Nature Genetics 2008, 40:560-566.
13. Murphy JM, Stewart RB, Bell RL, Badia-Elder NE, Carr LG, McBride
WJ, Lumeng L, Li TK: Phenotypic and genotypic characteriza-
tion of the Indiana University rat lines selectively bred for
high and low alcohol preference.  Behav Genet 2002,
32(5):363-388.
14. Hodgkinson CA, Yuan Q, Xu K, Shen PH, Heinz E, Lobos EA, Binder
EB, Cubells J, Ehlers CL, Gelernter J, et al.: Addictions biology:
haplotype-based analysis for 130 candidate genes on a single
array.  Alcohol Alcohol 2008, 43(5):505-515.
15. Glanz J, Grant B, Monteiro M, Tabakoff B: WHO/ISBRA Study on
State and Trait Markers of Alcohol Use and Dependence:
analysis of demographic, behavioral, physiologic, and drink-
ing variables that contribute to dependence and seeking
treatment. International Society on Biomedical Research on
Alcoholism.  Alcohol Clin Exp Res 2002, 26(7):1047-1061.
16. Churchill GA, Doerge RW: Empirical threshold values for quan-
titative trait mapping.  Genetics 1994, 138(3):963-971.
Additional file 1
Supplemental Methods and Results. Table S1: Identification of tran-
scription factors in eQTL on chromosome 6. Table S2: Distribution of cov-
ariates used for multivariate model with human subjects. Table S3: 
Demographic characteristics of human subjects. Table S4: Haplotype fre-
quencies and association with alcohol consumption in human subjects. 
Figure S1: Alcohol consumption levels in human subjects. Figure S2: Hap-
lotype block assessments. Figure S3: Relationship between alcohol con-
sumption and alcohol dependence in human subjects.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1741-
7007-7-70-S1.DOC]Page 20 of 23
(page number not for citation purposes)
BMC Biology 2009, 7:70 http://www.biomedcentral.com/1741-7007/7/7017. Broman KW, Wu H, Sen {, Churchill GA: R/qtl: QTL mapping in
experimental crosses.  Bioinformatics 2003, 19(7):889-890.
18. Brown VM, Ossadtchi A, Khan AH, Yee S, Lacan G, Melega WP,
Cherry SR, Leahy RM, Smith DJ: Multiplex three-dimensional
brain gene expression mapping in a mouse model of Parkin-
son's disease.  Genome Res 2002, 12(6):868-884.
19. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S,
Ellis B, Gautier L, Ge Y, Gentry J, et al.: Bioconductor: open soft-
ware development for computational biology and bioinfor-
matics.  Genome Biol 2004, 5(10):R80.
20. Kent WJ: BLAT--the BLAST-like alignment tool.  Genome Res
2002, 12(4):656-664.
21. Carlborg O, De Koning DJ, Manly KF, Chesler E, Williams RW, Haley
CS: Methodological aspects of the genetic dissection of gene
expression.  Bioinformatics 2005, 21(10):2383-2393.
22. Visscher PM, Thompson R, Haley CS: Confidence intervals in
QTL mapping by bootstrapping.  Genetics 1996,
143(2):1013-1020.
23. Bengtsson H, Simpson K, Bullard J, Hansen K: aroma.affymetrix: A
generic framework in R for analyzing small to very large
Affymetrix data sets in bounded memory.  In Tech Report #745
Berkeley: Department of Statistics, University of California; 2008. 
24. Affymetrix: Quality assessment of exon and gene arrays.
Affymetrix GeneChip® Gene and Exon Array Whitepaper Collection 2003.
25. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP:
Summaries of Affymetrix GeneChip probe level data.  Nucleic
Acids Res 2003, 31(4):e15.
26. Pritchard JK, Rosenberg NA: Use of unlinked genetic markers to
detect population stratification in association studies.  Am J
Hum Genet 1999, 65(1):220-228.
27. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visu-
alization of LD and haplotype maps.  Bioinformatics 2005,
21(2):263-265.
28. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B,
Higgins J, DeFelice M, Lochner A, Faggart M, et al.: The structure of
haplotype blocks in the human genome.  Science 2002,
296(5576):2225-2229.
29. The International HapMap Consortium: The International Hap-
Map Project.  Nature 2003, 426:789-796.
30. Schwarz G: Estimating the dimension of a model.  Annals of Sta-
tistics 1978, 6:461-464.
31. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a
practical and powerful approach to multiple testing.  JR Statist
Soc B 1995, 57:289-300.
32. Rhee SH, Hewitt JK, Young SE, Corley RP, Crowley TJ, Stallings MC:
Genetic and environmental influences on substance initia-
tion, use, and problem use in adolescents.  Arch Gen Psychiatry
2003, 60(12):1256-1264.
33. Kendler KS, Schmitt E, Aggen SH, Prescott CA: Genetic and envi-
ronmental influences on alcohol, caffeine, cannabis, and nic-
otine use from early adolescence to middle adulthood.  Arch
Gen Psychiatry 2008, 65(6):674-682.
34. Kuo PH, Aggen SH, Prescott CA, Kendler KS, Neale MC: Using a
factor mixture modeling approach in alcohol dependence in
a general population sample.  Drug Alcohol Depend 2008, 98(1-
2):105-114.
35. Hasin D, Hatzenbuehler ML, Keyes K, Ogburn E: Substance use
disorders: diagnostic and Statistical Manual of Mental Disor-
ders, fourth edition (DSM-IV) and International Classifica-
tion of Diseases, tenth edition (ICD-10).  Addiction 2006,
101(Suppl 1):59-75.
36. Moss HB, Chen CM, Yi HY: DSM-IV criteria endorsement pat-
terns in alcohol dependence: relationship to severity.  Alcohol
Clin Exp Res 2008, 32(2):306-313.
37. Koob GF: Neurobiological substrates for the dark side of
compulsivity in addiction.  Neuropharmacology 2009, 56(Suppl
1):18-31.
38. Saha TD, Chou SP, Grant BF: Toward an alcohol use disorder
continuum using item response theory: results from the
National Epidemiologic Survey on Alcohol and Related Con-
ditions.  Psychol Med 2006, 36(7):931-941.
39. Kozell LB, Hitzemann R, Buck KJ: Acute alcohol withdrawal is
associated with c-Fos expression in the basal ganglia and
associated circuitry: C57BL/6J and DBA/2J inbred mouse
strain analyses.  Alcohol Clin Exp Res 2005, 29(11):1939-1948.
40. Yoneyama N, Crabbe JC, Ford MM, Murillo A, Finn DA: Voluntary
ethanol consumption in 22 inbred mouse strains.  Alcohol 2008,
42(3):149-160.
41. Bachmanov AA, Kiefer SW, Molina JC, Tordoff MG, Duffy VB, Bar-
toshuk LM, Mennella JA: Chemosensory factors influencing
alcohol perception, preferences, and consumption.  Alcohol
Clin Exp Res 2003, 27(2):220-231.
42. Buemann B, Astrup A: How does the body deal with energy
from alcohol?  Nutrition 2001, 17(7-8):638-641.
43. Gao Q, Horvath TL: Neuronal control of energy homeostasis.
FEBS Lett 2008, 582(1):132-141.
44. Chen ZW, Chang CS, Leil TA, Olcese R, Olsen RW: GABAA
receptor-associated protein regulates GABAA receptor
cell-surface number in Xenopus laevis oocytes.  Mol Pharmacol
2005, 68(1):152-159.
45. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, Cone
RD: Integration of NPY, AGRP, and melanocortin signals in
the hypothalamic paraventricular nucleus: evidence of a cel-
lular basis for the adipostat.  Neuron 1999, 24(1):155-163.
46. Barnes S, Whistler HL, Hughes J, Woodruff GN, Hunter JC: Effect
of cholecystokinin octapeptide on endogenous amino acid
release from the rat ventromedial nucleus of the hypothala-
mus and striatum.  J Neurochem 1991, 56(4):1409-1416.
47. Berridge KC: Food reward: brain substrates of wanting and lik-
ing.  Neurosci Biobehav Rev 1996, 20(1):1-25.
48. Kelley AE: Ventral striatal control of appetitive motivation:
role in ingestive behavior and reward-related learning.  Neu-
rosci Biobehav Rev 2004, 27(8):765-776.
49. Palmiter RD: Is dopamine a physiologically relevant mediator
of feeding behavior?  Trends Neurosci 2007, 30(8):375-381.
50. Di Marzo V, Ligresti A, Cristino L: The endocannabinoid system
as a link between homoeostatic and hedonic pathways
involved in energy balance regulation.  Int J Obes (Lond) 2009,
33(Suppl 2):S18-24.
51. Lovinger DM: Presynaptic modulation by endocannabinoids.
Handb Exp Pharmacol 2008:435-477.
52. Viveros MP, de Fonseca FR, Bermudez-Silva FJ, McPartland JM: Crit-
ical role of the endocannabinoid system in the regulation of
food intake and energy metabolism, with phylogenetic,
developmental, and pathophysiological implications.  Endocr
Metab Immune Disord Drug Targets 2008, 8(3):220-230.
53. Kola B, Farkas I, Christ-Crain M, Wittmann G, Lolli F, Amin F, Harvey-
White J, Liposits Z, Kunos G, Grossman AB, et al.: The orexigenic
effect of ghrelin is mediated through central activation of the
endogenous cannabinoid system.  PLoS One 2008, 3(3):e1797.
54. Hentges ST, Low MJ, Williams JT: Differential regulation of syn-
aptic inputs by constitutively released endocannabinoids and
exogenous cannabinoids.  J Neurosci 2005, 25(42):9746-9751.
55. Matias I, Bisogno T, Di Marzo V: Endogenous cannabinoids in the
brain and peripheral tissues: regulation of their levels and
control of food intake.  Int J Obes (Lond) 2006, 30(Suppl 1):S7-S12.
56. Shi Y, Cheng D: Beyond triglyceride synthesis: the dynamic
functional roles of MGAT and DGAT enzymes in energy
metabolism.  Am J Physiol Endocrinol Metab 2009, 297(1):E10-18.
57. Mercer LD, Le VQ, Nunan J, Jones NM, Beart PM: Direct visualiza-
tion of cholecystokinin subtype2 receptors in rat central
nervous system using anti-peptide antibodies.  Neurosci Lett
2000, 293(3):167-170.
58. Ghijsen WE, Leenders AG, Wiegant VM: Regulation of chole-
cystokinin release from central nerve terminals.  Peptides
2001, 22(8):1213-1221.
59. Miller KK, Hoffer A, Svoboda KR, Lupica CR: Cholecystokinin
increases GABA release by inhibiting a resting K+ conduct-
ance in hippocampal interneurons.  J Neurosci 1997,
17(13):4994-5003.
60. Deng PY, Lei S: Bidirectional modulation of GABAergic trans-
mission by cholecystokinin in hippocampal dentate gyrus
granule cells of juvenile rats.  J Physiol 2006, 572(Pt 2):425-442.
61. Hugel S, Schlichter R: Presynaptic P2X receptors facilitate
inhibitory GABAergic transmission between cultured rat
spinal cord dorsal horn neurons.  J Neurosci 2000,
20(6):2121-2130.
62. Tiran Z, Peretz A, Attali B, Elson A: Phosphorylation-dependent
regulation of Kv2.1 Channel activity at tyrosine 124 by Src
and by protein-tyrosine phosphatase epsilon.  J Biol Chem 2003,
278(19):17509-17514.Page 21 of 23
(page number not for citation purposes)
BMC Biology 2009, 7:70 http://www.biomedcentral.com/1741-7007/7/7063. Lindblom J, Opmane B, Mutulis F, Mutule I, Petrovska R, Klusa V,
Bergstrom L, Wikberg JE: The MC4 receptor mediates alpha-
MSH induced release of nucleus accumbens dopamine.  Neu-
roreport 2001, 12(10):2155-2158.
64. Navarro M, Cubero I, Chen AS, Chen HY, Knapp DJ, Breese GR,
Marsh DJ, Thiele TE: Effects of melanocortin receptor activa-
tion and blockade on ethanol intake: a possible role for the
melanocortin-4 receptor.  Alcohol Clin Exp Res 2005,
29(6):949-957.
65. Polidori C, Geary N, Massi M: Effect of the melanocortin recep-
tor stimulation or inhibition on ethanol intake in alcohol-
preferring rats.  Peptides 2006, 27(1):144-149.
66. Reum T, Schafer U, Marsden CA, Fink H, Morgenstern R: Chole-
cystokinin increases extracellular dopamine overflow in the
anterior nucleus accumbens via CCK(B) receptors in the
VTA assessed by in vivo voltammetry.  Neuropeptides 1997,
31(1):82-88.
67. Stuber GD, Hopf FW, Hahn J, Cho SL, Guillory A, Bonci A: Volun-
tary ethanol intake enhances excitatory synaptic strength in
the ventral tegmental area.  Alcohol Clin Exp Res 2008,
32(10):1714-1720.
68. Davies DL, Machu TK, Guo Y, Alkana RL: Ethanol sensitivity in
ATP-gated P2X receptors is subunit dependent.  Alcohol Clin
Exp Res 2002, 26(6):773-778.
69. Xiao C, Ye JH: Ethanol dually modulates GABAergic synaptic
transmission onto dopaminergic neurons in ventral tegmen-
tal area: role of mu-opioid receptors.  Neuroscience 2008,
153(1):240-248.
70. Ridley AJ: Rho GTPases and actin dynamics in membrane pro-
trusions and vesicle trafficking.  Trends Cell Biol 2006,
16(10):522-529.
71. Kneussel M, Betz H: Clustering of inhibitory neurotransmitter
receptors at developing postsynaptic sites: the membrane
activation model.  Trends Neurosci 2000, 23(9):429-435.
72. Shen F, Lin Q, Gu Y, Childress C, Yang W: Activated Cdc42-asso-
ciated kinase 1 is a component of EGF receptor signaling
complex and regulates EGF receptor degradation.  Mol Biol
Cell 2007, 18(3):732-742.
73. Urena JM, La Torre A, Martinez A, Lowenstein E, Franco N, Winsky-
Sommerer R, Fontana X, Casaroli-Marano R, Ibanez-Sabio MA, Pas-
cual M, et al.: Expression, synaptic localization, and develop-
mental regulation of Ack1/Pyk1, a cytoplasmic tyrosine
kinase highly expressed in the developing and adult brain.  J
Comp Neurol 2005, 490(2):119-132.
74. Striggow F, Riek-Burchardt M, Kiesel A, Schmidt W, Henrich-Noack
P, Breder J, Krug M, Reymann KG, Reiser G: Four different types
of protease-activated receptors are widely expressed in the
brain and are up-regulated in hippocampus by severe
ischemia.  Eur J Neurosci 2001, 14(4):595-608.
75. Luo W, Wang Y, Reiser G: Protease-activated receptors in the
brain: receptor expression, activation, and functions in neu-
rodegeneration and neuroprotection.  Brain Res Rev 2007,
56(2):331-345.
76. Wang P, Kumar P, Wang C, Defea KA: Differential regulation of
class IA phosphoinositide 3-kinase catalytic subunits p110
alpha and beta by protease-activated receptor 2 and beta-
arrestins.  Biochem J 2007, 408(2):221-230.
77. Jacob TC, Moss SJ, Jurd R: GABA(A) receptor trafficking and its
role in the dynamic modulation of neuronal inhibition.  Nat
Rev Neurosci 2008, 9(5):331-343.
78. Motil J, Dubey M, Chan WK, Shea TB: Inhibition of dynein but not
kinesin induces aberrant focal accumulation of neurofila-
ments within axonal neurites.  Brain Res 2007, 1164:125-131.
79. Raff EC, Hoyle HD, Popodi EM, Turner FR: Axoneme beta-tubulin
sequence determines attachment of outer dynein arms.  Curr
Biol 2008, 18(12):911-914.
80. Samson HH, Tolliver GA, Schwarz-Stevens K: Oral ethanol self-
administration: a behavioral pharmacological approach to
CNS control mechanisms.  Alcohol 1990, 7(3):187-191.
81. Hyytiä P, Koob GF: GABAA receptor antagonism in the
extended amygdala decreases ethanol self-administration in
rats.  Eur J Pharmacol 1995, 283(1-3):151-159.
82. Di Chiara G, Acquas E, Tanda G: Ethanol as a neurochemical sur-
rogate of conventional reinforcers: the dopamine-opioid
link.  Alcohol 1996, 13(1):13-17.
83. Hodge CW, Haraguchi M, Chappelle AM, Samson HH: Effects of
ventral tegmental microinjections of the GABAA agonist
muscimol on self-administration of ethanol and sucrose.
Pharmacol Biochem Behav 1996, 53(4):971-977.
84. Samson HH, Chappell A: Muscimol injected into the medial pre-
frontal cortex of the rat alters ethanol self-administration.
Physiol Behav 2001, 74(4-5):581-587.
85. Samson HH, Chappell A: Injected muscimol in pedunculopon-
tine tegmental nucleus alters ethanol self-administration.
Alcohol 2001, 23(1):41-48.
86. Tabakoff B, Hoffman PL: Alcohol addiction: an enigma among
us.  Neuron 1996, 16(5):909-912.
87. Roberto M, Madamba SG, Moore SD, Tallent MK, Siggins GR: Etha-
nol increases GABAergic transmission at both pre- and post-
synaptic sites in rat central amygdala neurons.  Proc Natl Acad
Sci USA 2003, 100(4):2053-2058.
88. Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR:
Ethanol augments GABAergic transmission in the central
amygdala via CRF1 receptors.  Science 2004,
303(5663):1512-1514.
89. Lobo IA, Harris RA: GABA(A) receptors and alcohol.  Pharmacol
Biochem Behav 2008, 90(1):90-94.
90. Hodge CW, Chappelle AM, Samson HH: GABAergic transmis-
sion in the nucleus accumbens is involved in the termination
of ethanol self-administration in rats.  Alcohol Clin Exp Res 1995,
19(6):1486-1493.
91. Hnasko TS, Perez FA, Scouras AD, Stoll EA, Gale SD, Luquet S, Phil-
lips PE, Kremer EJ, Palmiter RD: Cre recombinase-mediated res-
toration of nigrostriatal dopamine in dopamine-deficient
mice reverses hypophagia and bradykinesia.  Proc Natl Acad Sci
USA 2006, 103(23):8858-8863.
92. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD: Locali-
zation of the melanocortin-4 receptor (MC4-R) in neuroen-
docrine and autonomic control circuits in the brain.  Mol
Endocrinol 1994, 8(10):1298-1308.
93. Kishi T, Aschkenasi CJ, Lee CE, Mountjoy KG, Saper CB, Elmquist JK:
Expression of melanocortin 4 receptor mRNA in the central
nervous system of the rat.  J Comp Neurol 2003, 457(3):213-235.
94. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Fer-
reira M, Tang V, McGovern RA, Kenny CD, et al.: Divergence of
melanocortin pathways in the control of food intake and
energy expenditure.  Cell 2005, 123(3):493-505.
95. Chung L, Moore SD: Cholecystokinin enhances GABAergic
inhibitory transmission in basolateral amygdala.  Neuropep-
tides 2007, 41(6):453-463.
96. Chhatwal JP, Gutman AR, Maguschak KA, Bowser ME, Yang Y, Davis
M, Ressler KJ: Functional interactions between endocannabi-
noid and CCK neurotransmitter systems may be critical for
extinction learning.  Neuropsychopharmacology 2009,
34(2):509-521.
97. Jhou TC, Fields HL, Baxter MG, Saper CB, Holland PC: The rostro-
medial tegmental nucleus (RMTg), a GABAergic afferent to
midbrain dopamine neurons, encodes aversive stimuli and
inhibits motor responses.  Neuron 2009, 61(5):786-800.
98. Hernández-Rabaza V, Hontecillas-Prieto L, Velazquez-Sanchez C, Fer-
ragud A, Perez-Villaba A, Arcusa A, Barcia JA, Trejo JL, Canales JJ:
The hippocampal dentate gyrus is essential for generating
contextual memories of fear and drug-induced reward.  Neu-
robiol Learn Mem 2008, 90(3):553-559.
99. Balasubramanian S, Fam SR, Hall RA: GABAB receptor associa-
tion with the PDZ scaffold Mupp1 alters receptor stability
and function.  J Biol Chem 2007, 282(6):4162-4171.
100. Fehr C, Shirley RL, Belknap JK, Crabbe JC, Buck KJ: Congenic map-
ping of alcohol and pentobarbital withdrawal liability loci to
a <1 centimorgan interval of murine chromosome 4: identi-
fication of Mpdz as a candidate gene.  J Neurosci 2002,
22(9):3730-3738.
101. Miller AD, Blaha CD: Midbrain muscarinic receptor mecha-
nisms underlying regulation of mesoaccumbens and nigros-
triatal dopaminergic transmission in the rat.  Eur J Neurosci
2005, 21(7):1837-1846.
102. Katner SN, McBride WJ, Lumeng L, Li TK, Murphy JM: Alcohol
intake of P rats is regulated by muscarinic receptors in the
pedunculopontine nucleus and VTA.  Pharmacol Biochem Behav
1997, 58(2):497-504.Page 22 of 23
(page number not for citation purposes)
BMC Biology 2009, 7:70 http://www.biomedcentral.com/1741-7007/7/70Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
103. Hsu R, Taylor JR, Newton SS, Alvaro JD, Haile C, Han G, Hruby VJ,
Nestler EJ, Duman RS: Blockade of melanocortin transmission
inhibits cocaine reward.  Eur J Neurosci 2005, 21(8):2233-2242.
104. Landgren S, Jerlhag E, Zetterberg H, Gonzalez-Quintela A, Campos J,
Olofsson U, Nilsson S, Blennow K, Engel JA: Association of pro-
ghrelin and GHS-R1A gene polymorphisms and haplotypes
with heavy alcohol use and body mass.  Alcohol Clin Exp Res 2008,
32(12):2054-2061.
105. Hansell NK, Agrawal A, Whitfield JB, Morley KI, Gordon SD, Lind PA,
Pergadia ML, Montgomery GW, Madden PA, Todd RD, et al.: Can we
identify genes for alcohol consumption in samples ascer-
tained for heterogeneous purposes?  Alcohol Clin Exp Res 2009,
33(4):729-739.
106. Belknap JK, Belknap ND, Berg JH, Coleman R: Preabsorptive vs.
postabsorptive control of ethanol intake in C57BL/6J and
DBA/2J mice.  Behav Genet 1977, 7(6):413-425.
107. Gentry RT, Dole VP: Why does a sucrose choice reduce the
consumption of alcohol in C57BL/6J mice?  Life Sci 1987,
40(22):2191-2194.
108. Jerlhag E, Egecioglu E, Landgren S, Salome N, Heilig M, Moechars D,
Datta R, Perrissoud D, Dickson SL, Engel JA: Requirement of cen-
tral ghrelin signaling for alcohol reward.  Proc Natl Acad Sci USA
2009, 106(27):11318-11323.
109. de Andrade M, Olswold CL, Slusser JP, Tordsen LA, Atkinson EJ, Rabe
KG, Slager SL: Identification of genes involved in alcohol con-
sumption and cigarettes smoking.  BMC Genet 2005, 6(Suppl
1):S112.
110. Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, Zill P, Maier
W, Moessner R, Gaebel W, Dahmen N, et al.: Genome-wide asso-
ciation study of alcohol dependence.  Arch Gen Psychiatry 2009,
66(7):773-784.
111. Bice P, Valdar W, Zhang L, Liu L, Lai D, Grahame N, Flint J, Li TK,
Lumeng L, Foroud T: Genomewide SNP screen to detect quan-
titative trait loci for alcohol preference in the high alcohol
preferring and low alcohol preferring mice.  Alcohol Clin Exp Res
2009, 33(3):531-537.
112. Bergeson SE, Kyle Warren R, Crabbe JC, Metten P, Gene Erwin V,
Belknap JK: Chromosomal loci influencing chronic alcohol
withdrawal severity.  Mamm Genome 2003, 14(7):454-463.
113. Agrawal A, Hinrichs AL, Dunn G, Bertelsen S, Dick DM, Saccone SF,
Saccone NL, Grucza RA, Wang JC, Cloninger CR, et al.: Linkage
scan for quantitative traits identifies new regions of interest
for substance dependence in the Collaborative Study on the
Genetics of Alcoholism (COGA) sample.  Drug Alcohol Depend
2008, 93(1-2):12-20.
114. Guerrini I, Cook CC, Kest W, Devitgh A, McQuillin A, Curtis D,
Gurling HM: Genetic linkage analysis supports the presence of
two susceptibility loci for alcoholism and heavy drinking on
chromosome 1p22.1-11.2 and 1q21.3-24.2.  BMC Genet 2005,
6(1):11.
115. Bergen AW, Yang XR, Bai Y, Beerman MB, Goldstein AM, Goldin LR:
Genomic regions linked to alcohol consumption in the Fram-
ingham Heart Study.  BMC Genet 2003, 4(Suppl 1):S101.
116. Wan S, Browning KN, Coleman FH, Sutton G, Zheng H, Butler A,
Berthoud HR, Travagli RA: Presynaptic melanocortin-4 recep-
tors on vagal afferent fibers modulate the excitability of rat
nucleus tractus solitarius neurons.  J Neurosci 2008,
28(19):4957-4966.
117. Kawaguchi Y, Kondo S: Parvalbumin, somatostatin and chole-
cystokinin as chemical markers for specific GABAergic
interneuron types in the rat frontal cortex.  J Neurocytol 2002,
31(3-5):277-287.
118. Xiao C, Zhou C, Li K, Davies DL, Ye JH: Purinergic type 2 recep-
tors at GABAergic synapses on ventral tegmental area
dopamine neurons are targets for ethanol action.  J Pharmacol
Exp Ther 2008, 327(1):196-205.Page 23 of 23
(page number not for citation purposes)
